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ABSTRACT 
 
 
Focal chondral defects impair considerably patients’ quality of life and may predispose 
for osteoarthritis. The strong association between age and increasing incidence of 
osteoarthritis marks it as an age related disease. However, osteoarthritis can be also 
consequence of other concomitant disorders; among these, the hereditary disease 
haemophilia stands out. The articular problems of patients with haemophilia begin still in 
infancy, when minor injuries result in recurrent haemarthroses that may predispose for 
haemophilic arthropathy. The lack of efficient modalities of treatment has prompted 
research into tissue engineering (TE), whose basic approach depends upon the interaction 
between cells, scaffolds and signalling factors to create in vitro a biological tissue 
construct to implant in vivo, mimicking the tissue of interest. Engineering cartilage is no 
exception to this approach. Such TE strategies are still adopted in orthopaedic surgical 
practice, providing for autologous chondrocytes implants with or without a supporting 
matrix in order to promote cartilage regeneration. Conversely, in patients with 
haemophilia, current available strategy can only slow the progression of joint damage, 
without recovery of tissue integrity. 
The aim of this work was twofold. At first, a novel supporting structure to treat focal 
articular defects was manufactured and characterized. Then, the feasibility of using 
haemophilic chondrocytes for autologous cartilage TE was considered.  
By a controlled chemical oxidation, 1% or 2% hydroxyls of the synthetic polymer 
polyvinyl alcohol (PVA) backbone were oxidized to carbonyls. Oxidation was verified 
by 2,4-dinitrophenylhydrazine assay and covalent binding with lysozyme. After physical 
cross-linking of polymeric solutions, 1% and 2% oxidized PVA scaffolds were evaluated 
and compared to neat PVA scaffolds. Scanning Electron Microscopy (SEM) micrographs 
showed oxidation to affect hydrogel surface continuity. Moreover, increasing carbonyls 
content, physical and biodegradation properties were modulated. In particular, 
mechanical properties, hydrodynamic radius of particles, thermal characteristics, and 
crystallinity degree of PVA hydrogels decreased with oxidation rate. Conversely, 
swelling behavior and protein release were enhanced, suggesting oxidized PVA 
potentiality as protein delivery system. Most important, biocompatibility and 
biodegradability of PVA scaffolds increased along with oxidation. After 12-week in vivo 
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implantation, hydrogels did not elicit severe inflammatory reactions. Nevertheless, a little 
limphomonocytic infiltration by CD3+ and F4/80+ cells suggested a role for inflammatory 
populations in implant reabsorption.  
Afterwards, Non-Haemophilic and Haemophilic chondrocytes were isolated and 
cultured. After a morphological evaluation through optical microscopy, cells were 
compared for the expression of specific mRNAs (COL2A1, COL9A3, COMP; ACAN; 
SOX9) by RT-PCR and specific surface markers (CD44; CD49c; CD49e; CD49f; 
CD151; CD26; CD73) by flow cytometry. RT-PCR results confirmed the expression of 
target genes and any immunophenotypic difference was observed despite haemophilic 
chondrocytes were exposed to blood in vivo which is one of the major responsible of 
cytotoxicity. Flow-cytometry showed that both subcultures consisted of 
CD44+/CD49c+/CD49e+/CD151+/CD73+/CD49f-/CD26- cells. High expression of 
adhesion molecules (e.g. CD44, CD49c, CD49e) involved in cell-cell or cell-matrix 
interactions, revealed high chondrogenic capacity. As it is well known PVA inability in 
sustaining cell adhesion, a bio-hybrid composite scaffold was than obtained combining 
the biomechanical properties of 1% oxidized PVA with an alternative matrix source that 
is decellularized Wharton’s jelly (W’s J). The hydrogel itself and the more specific 
decellularized articular cartilage (AC) matrix, combined with 1% oxidized PVA, were 
used as controls. Both cell populations behavior was evaluated after seeding cells on 
scaffolds. According to SEM micrographs and Thiazolyl Blue Tetrazolium Blue (MTT) 
proliferation assay, W’s J matrix showed a singular attitude in sustaining adhesion and 
proliferation of both cell populations.  
Our results highlighted oxidized PVA as a smart biomaterial useful for manufacturing 
scaffolds with customizable mechanical behaviour, protein-loading ability and 
biodegradability. Moreover, this study contributes to the definition of haemophilic 
chondrocytes phenotype, providing new potential markers to characterize them. Our 
preliminary evidences support the chance of using haemophilic chondrocytes for 
autologous implant in haemophilic patients. One percent-oxidized PVA/W’s J may be 
considered as an innovative and easily available scaffold for cartilage restoration both in 
Haemophilic and Non-Haemophilic patients. 
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RIASSUNTO 
 
 
I difetti condrali focali compromettono significativamente la qualità della vita dei pazienti 
predisponendo all'osteoartrite. Eziologicamente sussiste una forte associazione tra l'età 
del paziente e l’incidenza di osteoartrite, consentendo di identificarla come una malattia 
legata all’invecchiamento. L’osteoartrite tuttavia può essere anche conseguenza di 
patologie concomitanti; tra queste l’emofilia, coagulopatia ereditaria. I problemi articolari 
nei pazienti emofilici esordiscono già nell’infanzia, quando danni minori possono esitare 
in emartri ricorrenti predisponendo all’artropatia emofilica.  
L’assenza di trattamenti soddisfacenti per efficacia ha spinto la ricerca nell’ambito 
dell’ingegneria tissutale, il cui approccio di base si fonda sull’interazione tra cellule, 
scaffolds e fattori di crescita. L’obiettivo è di creare in vitro costrutti biologici funzionali, 
capaci di mimare il tessuto d’interesse dopo impianto.  
Alcune strategie di ingegneria tissutale sono già adottate in chirurgia ortopedica. Esse 
prevedono l’impianto di condrociti autologhi come tali o supportati da matrici al fine di 
promuovere la rigenerazione e quindi l’integrità del tessuto compromesso. Di esse 
tuttavia i pazienti emofilici non possono beneficiare, disponendo ad oggi di approcci volti 
a rallentare solamente la progressione del danno senza favorirne il recupero. 
Lo scopo di questo lavoro di Tesi è stato duplice. Dapprima è stato realizzato e 
caratterizzato un nuovo scaffold funzionale al recupero del danno cartilagineo focale. 
Successivamente, è stata valutata la possibilità di utilizzare i condrociti del paziente 
emofilico nella prospettiva di un impianto autologo.  
Mediante una reazione chimica di ossidazione, l’1% o il 2% dei gruppi ossidrilici presenti 
sul backbone del polimero sintetico polyvinyl alcohol (PVA) sono stati ossidati a gruppi 
carbonilici. L’avvenuta ossidazione è stata verificata mediante saggio con 2,4-
dinitrofenilidrazina e binding covalente di lisozima. A seguito di cross-linking fisico delle 
soluzioni polimeriche, scaffolds in PVA ossidato all’1% ed al 2% sono stati quindi 
valutati e confrontati con scaffolds in PVA non ossidato.  
La microscopia elettronica a scansione ha rivelato come l’impiego di soluzioni 
polimeriche ossidate influenzi la continuità superficiale degli idrogeli risultanti. Inoltre, 
aumentando il contenuto in carbonili, anche le proprietà fisiche e di biodegradazione 
risultano modulate. In particolare, la meccanicità degli scaffolds, il raggio idrodinamico 
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delle particelle, le proprietà termiche ed il grado di cristallinità degli idrogeli di PVA 
diminuiscono all’aumentare del grado di ossidazione. Diversamente, il rigonfiamento ed 
il rilascio proteico aumentano, suggerendo potenzialità di protein-delivery system. Anche 
le caratteristiche di biocompatibilità e biodegradazione sono state considerate. Dopo 12 
settimane di impianto sottocutaneo in vivo, gli idrogeli non hanno provocato gravi 
reazioni infiammatorie. Tuttavia, una limitata infiltrazione linfomonocitaria da parte di 
cellule CD3+ e F4/80+ ha suggerito un ruolo delle popolazioni infiammatorie nel 
riassorbimento dell’impianto: all’aumento del grado di ossidazione è stato riscontrato un 
incremento del tasso di degradazione degli scaffolds.  
I condrociti da paziente emofilico e non emofilico sono stati quindi isolati e messi in 
coltura. Dopo valutazione morfologica mediante microscopia ottica, le cellule sono state 
comparate per l’espressione di specifici mRNA (COL2A1; COL9A3; COMP; ACAN; 
SOX9) attraverso RT-PCR; e per l’espressione di marker di superficie caratteristici 
(CD44; CD49c; CD49e; CD49f; CD151; CD26; CD73) attraverso analisi di 
citofluorimetria. I risultati di RT-PCR hanno confermato l’espressione dei geni target; 
inoltre differenze immunofenotipiche non sono state osservate tra i tipi cellulari sebbene 
i condrociti da paziente emofilico fossero stati esposti in vivo al sangue, tra i maggiori 
responsabili di citotossicità. La citofluorimetria ha mostrato dunque che entrambe le 
popolazioni presentavano cellule con immunofenotipo 
CD44+/CD49c+/CD49e+/CD151+/CD73+/CD49f-/CD26-. L’elevata espressione di 
molecole di adesione (e.g. CD44, CD49c, CD49e) coinvolte in interazioni cellula-cellula 
o cellula-matrice, ha suggerito un alto potenziale condrogenico.  
Essendo nota l’inadeguatezza del PVA nel promuovere l’adesione cellulare, è stato 
realizzato uno scaffold bio-ibrido composito combinando le proprietà meccaniche del 
PVA ossidato all’1% con una matrice extracellulare decellularizzata non tessuto 
specifica: la gelatina di Wharton (W’s J). L’idrogel tal quale e la più specifica matrice da 
cartilagine articolare decellularizzata, combinata con il PVA ossidato all’1%, sono stati 
usati come controllo.  
Il comportamento di entrambe le popolazioni cellulari è stata valutata dopo semina sugli 
scaffolds. Immagini di microscopia elettronica a scansione ed il saggio di proliferazione 
con Thiazolyl Blue Tetrazolium Blue (MTT) hanno mostrato come la matrice da W’s J 
sostenga in modo singolare l’adesione e la proliferazione di entrambe le popolazioni 
cellulari.  
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I risultati di questo lavoro di Tesi hanno consentito di identificare nel PVA ossidato un 
biomateriale intelligente per la realizzazione di scaffolds con proprietà meccaniche, di 
protein-loading, e di biodegradazione modulabili. Inoltre, questo studio ha contribuito a 
definire il fenotipo dei condrociti da paziente emofilico, provvedendo a fornire nuovi 
potenziali marker per caratterizzarli e suggerendo la possibilità di impianto autologo. Lo 
scaffold composito PVA ossidato 1%/W’J potrebbe infine essere considerato come una 
struttura innovativa per il recupero del danno cartilagineo sia in pazienti affetti da 
osteoartrite idiopatica che secondaria. 
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INTRODUCTION 
 
 
1. Impact of musculoskeletal disorders on the individual  
Over the past century, global priorities in health have been largely focussed on 
communicable diseases. With the World's population growth, increased average age and 
decreased death rates, people are now living longer and becoming increasingly 
susceptible to non-communicable diseases, including musculoskeletal (MSK) disorders 
(March et al., 2014). 
According to Global Burden of Disease (GBD) Study (Lim et al., 2012), regarding 187 
countries and 21 regions of the world for the years 1990 and 2010, MSK disorders prove 
to be the second most common cause of disability world-wide, measured by years lived 
with disability (YLDs) (Lim et al., 2012; Storheim et Zwart, 2014). Affecting one in four 
adults across Europe, they influence all aspects of life through pain and by limiting 
activities of daily living with also an enormous economic impact on society through both 
direct health expenditure related to treating the sequelae of the conditions and indirectly 
through loss of productivity (Woolf et al., 2012).  
Even though MSK conditions are a diverse group of disorders with regard to 
pathophysiology, they are linked anatomically and by their association with pain and 
impaired physical function (Woolf et al., 2010). They may involve a number of different 
anatomical structures such as bone, joints and the periarticular structures which includes 
muscles, tendons, ligaments or bursae (Mody et Brooks, 2012). 
In the burden estimates, there were five major defined conditions: i. osteoarthritis (OA); 
ii. rheumatoid arthritis; iii. gout; iv. low back pain; v. neck pain (March et al., 2014). 
Articular cartilage (AC) plays a vital role in the function of the MSK system: frictionless 
motion between the articular surfaces of diarthrodial joints as well as loading distribution 
depends on its unique properties. Damage or degeneration of this remarkable tissue 
decreases mobility and frequently causes pain with movement and, in the most severe 
instances, deformity, severe chronic pain and increasing disability (Buckwalter 1998; 
Cohen et al., 1998; Al Maini et al., 2014). Due to the poor intrinsic ability of this tissue 
for repair, injuries to AC are one of the most challenging issues of MSK medicine 
(Vinatier et al., 2009a; Vinatier et al., 2009b).  
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2. Basic science of articular cartilage 
In cartilage, under normal physiological conditions, degradation and synthesis of 
extracellular matrix (ECM) molecules are maintained in a state of balance; any disruption 
results in cartilage degeneration (Lane Smith et al., 2000). 
In order to understand better AC diseases and developing treatments, its normal 
morphology and functioning must be well-understood (Cohen et al., 1998). 
 
2.1 Anatomy  
Hyaline AC is aneural, avascular and alymphatic connective tissue that covers the 
articulating ends of diarthrodial joints. It is composed of a single type of cell, 
chondrocytes, responsible for the production, organization and maintenance of an 
abundant and highly complex ECM.  
Articular cartilage ECM consists primarily of high concentration of proteoglycans, 
entangled in a dense network of collagen fibres, and a large amount of water (Poole 1997; 
Alexopoulos et al., 2005; Rogers et al., 2006; Martel-Pelletier et al., 2008). 
Chondrocytes that form only 1–5% of cartilage volume, receive their nutrition by 
diffusion through matrix, which represents only about 20% of the tissue wet weight 
(Bhosale et Richardson 2008). Water, mainly of extracellular origin, and inorganic salts 
dissolved in it (i.e., sodium, calcium, and potassium chloride) constitute most of the 
remaining tissue and are unevenly distributed depending on deep. Water highest 
concentration (80%) is found near the cartilage surface, decreasing gradually to reach 
about 65% in the deep zone. Beyond assuring nutrients diffusion from the synovial fluid, 
it is essential for tissue lubrication and resiliency. The maintenance and flow of water in 
the tissue relies on its interaction with ECM macromolecules (Martel-Pelletier et al., 
2008).  
 
 2.2 Macromolecules of cartilage extracellular matrix  
The ECM of AC is a unique environment (Gao et al., 2014). Chondrocytes form the 
macromolecular framework of cartilage tissue matrix from three classes of molecules: a) 
collagens; b) proteoglycans; c) non-collagenous proteins (Buckwalter et Mankin 1998) 
(Fig. 1). 
 
Introduction 
9 
 
 
Figure 1. Three classes of proteins exist in articular cartilage: collagens (mostly type II collagen); 
proteoglycans (primarily aggrecan); and other noncollagenous proteins (including link protein, fibronectin, 
cartilage oligomeric matrix protein) and the smaller proteoglycans (biglycan, decorin and fibromodulin). 
The interaction between highly negatively charged cartilage proteoglycans and type II collagen fibrils is 
responsible for the compressive and tensile strength of the tissue, which resists load in vivo. Abbreviation: 
COMP, cartilage oligomeric matrix protein. 
 
a) Collagens 
Collagens form the endoskeleton of AC. In particular, collagen types found in it are: type 
II, VI, IX, X, and XI. Despite type II collagen accounts for 90-95%, all contribute to the 
mature matrix arrangement. Type II, IX, and XI collagens form a fibrillary meshwork that 
lend tensile stiffness and strength to tissue. In particular, high amount of carbohydrate 
groups in collagen type II allows more interaction with water than other types. Type VI 
collagen forms part of the matrix immediately surrounding the chondrocytes and may 
help them to attach to the macromolecular framework of the matrix. Type X is closely 
related to the hypertrophied cells in calciﬁed cartilage layer providing structural support 
and aiding in cartilage mineralization (Cohen et al., 1998; Salter, 1998; Temenoff et 
Mikos, 2000; Bhosale et Richardson, 2008).  
b) Proteoglycans 
Proteoglycans are protein polysaccharide molecules produced inside the chondrocytes 
and secreted in the matrix, providing a compressive strength to the AC. There are two 
major classes of proteoglycans found in AC, large aggregating proteoglycan monomers 
(or aggrecans) and small proteoglycans including decorin, biglycan and fibromodulin. 
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The subunits of proteoglycans are called as glycosaminoglycans (GAGs). These are 
disaccharide molecules, with main two types, chondroitin sulphate and keratin sulphate. 
GAGs are bound to the protein core by means of sugar bonds, to form aggrecan molecule. 
Link protein stabilizes this chain with a central hyaluronic acid chain to form an intricate 
structure of the GAG molecule. 
Proteoglycans maintain the fluid and electrolyte balance in the AC. These 
macromolecules have negatively charged sulphate and carboxylate groups, which in turn 
attract only positively charged molecules and repel the negative molecules. This increases 
the total concentration of inorganic ions (i.e., sodium) inside the matrix, thereby 
increasing osmolarity of the AC, thus creating a Donnan effect (Temenoff et Mikos, 2000; 
Bhosale et Richardson, 2008). 
c) Non-collagenous proteins 
In contrast to proteoglycans, glycoproteins have only a small amount of oligosaccharide 
associated with the protein core. These polypeptides help to stabilize the ECM matrix and 
aid in chondrocyte-matrix interactions. Both anchorin CII and cartilage oligomeric matrix 
protein (COMP) anchor chondrocytes to the surrounding matrix; in particular, COMP 
may have also value as a marker of turnover and degeneration of cartilage.  
Other non-collagenous proteins commonly found in most tissues, such as fibronectin and 
tenascin, are observed even in AC, and are believed to perform similar functions as the 
glycoproteins (Buckwalter et Mankin, 1998; Temenoff et Mikos, 2000). 
 
2.3 Ultrastructure of articular cartilage: zones and regions 
Chondrocytes organize the collagen, proteoglycans and non-collagenous proteins into a 
unique and highly specialized tissue arranged in different zones and regions. 
 
2.3.1 Zones 
The composition, structure and functions of chondrocytes vary depending on the depth 
from the surface of the cartilage. Morphologically there are four named zones, from top 
to bottom (Youn et al., 2006; Bhosale et Richardson 2008): a) superficial zone; b) 
transitional zone; c) deep zone; d) calcified cartilage zone. These distinct tissue zones 
exhibit different biomechanical properties and rates of cell metabolic activities, 
suggesting differential adaptations to distinct biomechanical roles (Quinn et al., 2005). 
Each zone possesses attributes necessary to make AC as a completely strong, durable, 
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and more able to withstand shear and axial forces through a joint. From the superficial to 
the deep zone, cell density progressively decreases, whereas cell volume and the 
proportion of proteoglycan relative to collagen increases (Fig. 2) (Goldring et Marcu 
2009). 
 
 
Figure 2. Schematic image demonstrating chondrocyte organization in the three main zones of uncalcified 
cartilage: superficial zone; transitional zone; deep zone. Note changes in collagen fibre orientation from the 
superficial to the deep zone. Chondrocyte orientation also changes from the superficial zone (densely 
packed, flat) to the deep zone (columnar orientation perpendicular to the surface). The tidemark represents 
a relative change from the deep zone to the zone of calcified cartilage. 
 
a) Superficial zone 
The superficial zone protects deeper cartilage layers from shear stresses and makes up 
approximately 10% to 20% of AC thickness. It is made of two distinct layers. An acellular 
sheet of mainly collagen fibers (the lamina splendens) that covers the joint and deeply a 
second layer composed of flattened chondrocytes, parallel to the articular surface. The 
ECM in this area has less proteoglycan than the other zones and more densely packed 
collagen fibres, fibronectin and water. It is in contact with synovial fluid and is 
responsible for most of the tensile properties of cartilage, which enable it to resist the 
sheer, tensile, and compressive forces imposed by articulation (Poole, 1997; Martel-
Pelletier et al., 2008).  
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b) Transitional zone 
Immediately deep to the superficial zone is the transitional zone, which provides an 
anatomic and functional bridge between the superficial and deep zones. The transitional 
zone includes chondrocytes that are spherical; the ECM in this area has larger collagen 
fibrils, more proteoglycan and less collagen and water than in the previous zone.  
c) Deep zone 
The deep zone is responsible for providing the greatest resistance to compressive forces, 
given that collagen fibrils are arranged perpendicular to the articular surface. It contains 
the largest diameter collagen fibrils, the highest proteoglycan content, and the lowest 
water concentration. The cells are rounded, like in the transitional zone, but are stacked 
in columns perpendicular to the articulating surface and parallel to the collagen fibres. 
The deep zone represents approximately 40-60% of AC volume (Poole, 1997; Sophia Fox 
et al., 2009; Goldring et Marku 2009).  
d) Calcified zone 
The calcified zone plays an integral role in securing the cartilage to bone, by anchoring 
the collagen fibrils of the deep zone to subchondral bone. In this zone, the cell population 
is scarce and chondrocytes are hypertrophic. In some places, they seem to be completely 
surrounded by calcified ECM, indicating their little metabolic activity (Sophia Fox et al., 
2009). 
 
2.3.2 Regions 
In addition to zonal variations in structure and composition, the AC matrix consists of 
several distinct regions based on proximity to the chondrocytes. Hence, the ECM can be 
divided into: a) pericellular region; b) territorial region; c) inter-territorial region (Youn 
et al., 2006) (Fig. 3). 
 
a) Pericellular region 
The pericellular region is a thin layer adjacent to the cell membrane that completely 
surrounds the chondrocyte. It contains mainly proteoglycans, as well as glycoproteins and 
other non-collagenous proteins. This matrix region may play a functional role to initiate 
signal transduction within cartilage with load bearing.  
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b) Territorial region 
The territorial region surrounds the pericellular matrix; it is composed mostly of fine 
collagen fibrils, forming a basketlike network around the cells. This region is thicker than 
the pericellular matrix and it may protect chondrocytes against mechanical stresses, 
contributing to the resiliency of the AC structure and withstanding substantial loads.  
c) Inter-territorial region 
The inter-territorial region is the largest of the three regions. With its abundant 
proteoglycans and randomly oriented bundles of large collagen fibrils, it contributes most 
to the biomechanical properties of AC (Sophia Fox et al., 2009; Temenoff et Mikos 2000). 
 
 
 
Figure 3. The cartilage matrix surrounding chondrocytes in healthy articular cartilage is arranged into zones 
defined by their distance from the cell: the pericellular matrix; the territorial matrix; the interterritorial 
matrix. Abbreviations: CILP-1, cartilage intermediate layer protein 1; COMP, cartilage oligomeric matrix 
protein; CS, chondroitin sulfate; KS, keratan sulfate; PRELP, proline-arginine-rich end leucine-rich repeat 
protein (Heinegård et Saxne, 2011). 
 
2.4 Articular cartilage metabolism 
Chondrocytes are responsible for the regulation of ECM turnover by synthesizing and 
secreting cartilage-specific matrix proteins. In adulthood, these large round cells no 
longer divide, and are called post-mitotic. Therefore, the cartilage has a low turnover rate 
and a very limited ability for self-repair.  
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Articular cartilage is avascularised, and chondrocytes function with a hypoxic (physioxic) 
metabolism: nutrients and oxygen are supplied to the cells primarily by diffusion from 
the synovial fluid and subchondral bone. From the most superficial to the deepest layers, 
it is estimated that the oxygen gradient ranges from 10 to 1%, respectively. In these 
conditions of hypoxia, chondrocytes metabolize glucose into energy substrates via the 
anaerobic glycolysis pathway. Glucose is a sugar essential for the proper functioning of 
cellular machinery and in particular, it is essential for cartilage, being required for GAGs 
synthesis. Like oxygen, it diffuses from the synovial fluid and into the chondrocyte 
through glucose transporters called GLUT (GLUT1,3, 5, 9, 10 and 11) (Fig. 4). 
 
 
 
Figure 4. Model of glucose diffusion and transport in AC. Glucose is delivered to the chondrocyte via the 
synovial microcirculation and take up by GLUT proteins. Intracellular glucose is accumulated in two 
distinct pools; the metabolic pool used for glycolysis and the structural pool used for synthesis of ECM 
macromolecules. 
 
The chondrocytes maintain the surrounding matrix by modulating the balance between 
the synthesis and degradation of various ECM components in physiopathological 
situations. This balance is controlled by the relative amounts of cytokines and growth 
factors in the cartilage or synovial fluid. Chondrocytes synthesize ECM molecules, but 
also factors involved in ECM degradation such as metalloproteinases (MMPs) 
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collagenase, gelatinase, stromelysin and the cathepsins (cathepsin B and D). Collagenase 
degrades native helical collagen fibrils at a single site. Gelatinase degrades denatured type 
II and type IV collagen; it also has significant activity against fibronectin, elastin, and 
collagen types V, VII, X, and XI. The role of stromelysin is to degrade the protein core 
of aggrecan. All metalloproteinases are secreted as latent proenzymes that require 
activation extracellularly. Cathepsins are active in the degradation of aggrecan. 
Cartilage cells do not directly interact with each other but are linked to the ECM by 
surface receptors such as integrins. Hence, the chondrocyte has a close relationship with 
its microenvironment and is sensitive to changes in it..  
The development of disease such as osteoarthritis is associated with dramatic changes in 
cartilage metabolism. This occurs when there is a physiological imbalance of degradation 
and synthesis by chondrocytes (Sophia Fox et al., 2009; Demoor et al., 2014) (Fig. 5). 
 
 
Figure 5. Factors affecting cartilage anabolism and catabolism. 
 
2.5 Biomechanical function  
Articular cartilage is a thin layer of specialized connective tissue with unique viscoelastic 
properties. Its principal functions are to provide a smooth, lubricated surface for low 
friction articulation and to facilitate the transmission of loads to the underlying 
subchondral bone. Articular cartilage is unique in its ability to withstand high cyclic 
loads, demonstrating little or no evidence of damage or degenerative change.  
The biomechanical behaviour of AC is best understood when the tissue is viewed as a 
biphasic medium. Its consists of two phases: a fluid phase and a solid phase. Water is the 
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principal component of the fluid phase, contributing up to 80% of the wet weight of the 
tissue. The solid phase is characterized by the ECM, which is porous and permeable. The 
relationship between proteoglycan aggregates and interstitial fluid provides compressive 
resilience to cartilage through negative electrostatic repulsion forces. The initial and rapid 
application of articular contact forces during joint loading causes an immediate increase 
in interstitial fluid pressure. This local increase in pressure causes the fluid to flow out of 
the ECM, generating a large frictional drag on the matrix. When the compressive load is 
removed, interstitial fluid flows back into the tissue. The low permeability of AC prevents 
fluid from being quickly squeezed out of the matrix. The two opposing bones and 
surrounding cartilage confine the cartilage under the contact surface. These boundaries 
are designed to restrict mechanical deformation.  
Articular cartilage is viscoelastic and exhibits time-dependent behaviour when subjected 
to a constant load or deformation. Two types of mechanisms are responsible for 
viscoelasticity in AC: flow dependent and flow independent. The flow-dependent 
mechanism depends on interstitial fluid and the frictional drag associated with this flow. 
The drag resulting from the interstitial fluid is known as biphasic viscoelastic behaviour. 
The flow-independent component of viscoelasticity is caused by macromolecular 
motion— specifically, the intrinsic viscoelastic behaviour of the collagen-proteoglycan 
matrix. As a result, the fluid pressure provides a significant component of total load 
support, thereby reducing the stress acting upon the solid matrix.  
Articular cartilage also exhibits a creep and stress-relaxation response. When a constant 
compressive stress is applied to the tissue, its deformation increases with time, and it will 
deform or creep until an equilibrium value is reached. Similarly, when cartilage is 
deformed and held at a constant strain, the stress will rise to a peak, which will be 
followed by a slow stress-relaxation process until an equilibrium value is reached. 
Because AC tends to stiffen with increased strain, it cannot be described by a single 
Young’s modulus. Rather, the modulus of the tissue depends on the time at which the 
force measurement was taken during a stress-relaxation test, which was common practice 
in the preliminary studies of mechanical testing on AC. The current method is to apply a 
known strain, which is immediately followed by a peak in measured force and a slow 
stress-relaxation process; the force/stress value is recorded when it has reached 
equilibrium. This process is repeated across a range of strain values, and the equilibrium 
modulus is calculated as the slope of the stress-strain curve.  
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Mechanical force has long been appreciated as a regulator of musculoskeletal tissues, and 
may be the most important single environmental factor responsible for joint homeostasis. 
The complex composition and organization of cartilage through the middle zones of 
cartilage contributes significantly to its shear-resistant properties. Stretching of the 
randomly distributed collagen fibrils provides cartilage with its shear stress response. The 
tensile force-resisting properties derive from the precise molecular arrangement of 
collagen fibrils. The stabilization and ultimate tensile strength of the collagen fiber are 
thought to result from the intra- and intermolecular cross-links (Sophia Sophia Fox et al., 
2009) 
 
3. Osteoarthritis features 
Amongst MSK disorders, OA is the most common joint disease (Buckwalter et al., 2006) 
and is recognized as a major cause of pain and disability (Buckwalter et al., 2004). It 
develops most commonly in the absence of a known cause of joint degeneration, a 
condition referred to as primary or idiopathic OA. Less frequently, it develops as a result 
of joint degeneration caused by injuries or a variety of hereditary, inflammatory, or 
developmental, metabolic disorders, a group of conditions referred to as secondary OA 
(Buckwalter et al., 2000; Beris et al., 2005) (Tab. 1). 
 
 
Table 1. Proposal for differentiation of clinical phenotypes of osteoarthritis. 
 
3.1 Pathogenesis of idiopathic osteoarthritis 
In addition to the involvement of several joint tissues, OA has long been mainly 
characterised by a failure of the repair process of damaged cartilage due to biomechanical 
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and biochemical changes in the joint. Cartilage is non-vascularised, so this restricts the 
supply of nutrients and oxygen to the chondrocytes that are responsible for the 
maintenance of a very large amount of ECM. At an early stage, in an attempt to effect a 
repair, clusters of chondrocytes form in the damaged areas and the concentration of 
growth factors in the matrix rises. This attempt subsequently fails and leads to an 
imbalance in favour of degradation. Increased synthesis of tissue-destructive proteinases 
(matrix MMP and agrecanases), increased apoptotic death of chondrocytes, and 
inadequate synthesis of components of the ECM, lead to the formation of a matrix that is 
unable to withstand normal mechanical stresses. Consequently, the tissue enters a vicious 
cycle in which breakdown dominates synthesis of ECM. Since AC is aneural, these 
changes do not produce clinical signs unless innervated tissues become involved. This is 
one reason for the late diagnosis of osteoarthritis. 
Although the pathophysiology of osteoarthritis has long been thought to be cartilage 
driven, recent evidence shows an additional and integrated role of bone and synovial 
tissue, and patchy chronic synovitis is evident in the disease. Synovial inflammation 
corresponds to clinical symptoms such as joint swelling and inflammatory pain, and it is 
thought to be secondary to cartilage debris and catabolic mediators entering the synovial 
cavity. Synovial macrophages produce catabolic and pro-inflammatory mediators and 
inflammation starts negatively affecting the balance of cartilage matrix degradation and 
repair. This process in turn amplifies synovial inflammation, creating a vicious cycle. 
Synovial inflammation happens in early as well as late phases of OA and is seldom as 
severe as in rheumatoid arthritis, but it might add to the vicious cycle of progressive joint 
degeneration. The main characteristics of OA are changes in the subchondral bone. 
Osteophyte formation, bone remodelling, subchondral sclerosis, and attrition are crucial 
for radiological diagnosis. Several of these bone changes take place not only during the 
final stage of the disease, but also at the onset of the disease (Bijlsma et al., 2011) (Fig. 
6). 
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Figure 6. Schematic drawing of an osteoarthritic joint. The different tissues involved in clinical and 
structural changes of the disease are shown on the left. Note that cartilage is the only tissue not innervated. 
On the right the bidirectional interplay between cartilage, bone, and synovial tissue involved in 
osteoarthritis is shown, and the two-way interaction between this interplay and the ligaments and muscles. 
In the interplay between cartilage, bone, and synovial tissue one of the tissues might dominate the disease, 
and as such should be targeted for treatment (Bijlsma et al., 2011). 
 
3.2 Pathogenesis of haemophilic arthropathy 
Haemophilia is an X-linked heritable coagulopathy with an overall prevalence of 
approximately 1 in 10,000 individuals. The most common form is factor (F) VIII 
deﬁciency, or haemophilia A, which comprises approximately 80% of cases. Factor IX 
deﬁciency, or haemophilia B, comprises approximately 20% of cases (Knobe et Berntorp 
2011). It generally affects males on the maternal side, however, FVIII and FIX genes are 
prone to new mutations, and as many as 1/ of all cases are the result of spontaneous 
mutations where there is no prior family history.  
The severity of haemophilia is classified according to the amount of circulating functional 
clotting factor: patients with <1% have severe disease, those with 1–5% are moderate, 
and those with >5% are classified as mild. The characteristic phenotype of haemophilia 
is the bleeding tendency. Patients with severe haemophilia experience frequent 
spontaneous bleeding episodes, in contrast to those with moderate and mild haemophilia 
in whom trauma or surgery is usually required to provoke haemorrhage. Although 
bleeding can occur at almost any site, haemarthrosis (intra-articular bleeding) is the most 
common clinical manifestation, and the ankles, knees and elbows are most frequently 
affected (Tab. 2) (Raffini et Manno, 2007). 
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Table 2. Approximate frequency of bleeding at different sites 
 
The consequence of repeated extravasation of blood into joint cavities hesitates in 
haemophilic arthropathy which is characterized by two main features (i.e., chronic 
synovitis and cartilage destruction).  
Haemophilic synovitis is a proliferative disorder of the synovial tissue. Within hours of 
the extravasation of blood into a joint, distension of the joint capsule occurs, followed by 
an acute reaction of the synovial tissue with infiltration of polymorphonuclear cells and 
later monocytes and lymphocytes. This acute episode of haemarthrosis is resolved in 
about one week, the blood being progressively removed from the joint space by the 
synovial lining cells and invading macrophages. However, after repeated episodes of 
intra-articular bleeding, the blood removal capacity is exceeded and blood stays longer in 
the joint space. This leads to the deposition of iron contained in red blood cells in the 
synovial membrane. With each successive haemorrhage, there is a progressive 
accumulation of iron, as haemosiderin in the synovial membrane. This is postulated to be 
a major trigger of chronic synovitis, iron being involved in both synovial cell proliferation 
and vascular cell proliferation in the subsynovial layer. Although a normal synovial 
membrane is thin and mostly avascular, the proliferation of the synovium and 
neovascularization of the subsynovial layer result in an inflamed, villous, friable and 
highly vascular synovial tissue, more susceptible to further haemorrhage with minimal 
stress, which sets up a vicious circle. The overgrowth of the synovial membrane also 
causes pain and mechanical dysfunction of the joint. The cartilage destruction results 
from the production of enzymes and cytokines by inflammatory cells which have 
infiltrated the synovial membrane. Furthermore, it is favoured by the mechanical 
distension of the joint capsule and the increase in pressure in the joint space caused by 
the presence of blood which induces the apoptosis of chondrocytes and an inhibition of 
proteoglycan synthesis. The cartilage is thereby unable to restore the synthesis of the 
cartilage matrix, leading to a long-lasting joint damage. With time, a crippling arthritis 
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develops and the final result is a fibrotic and destroyed joint. In summary, haemophilic 
arthropathy shows characteristics of both inflammatory and degenerative joint disease 
(Fig. 7) (Lafeber et al., 2008). 
 
 
Figure 7. General scheme of the pathogenesis of haemophilic arthropathy (Lafeber et al., 2008). 
 
4. Classification of cartilage injuries 
Both in primary or secondary OA, the early stages of disease are difficult to diagnose. 
Joint structure and function are typically altered substantially before symptoms cause 
patients to seek medical care; that is, the osteoarthritic process begins long before OA 
presents as a clinical disease. The insidious onset and “silent” progression of OA not only 
obscure an early diagnosis, but also delay treatment that may help prevent further 
cartilage destruction and joint failure (Matyas et al., 2004). 
To guide management decisions and understand the prognosis of AC lesions it is 
important and necessary to document and grade them.  
Cartilage lesions are determined by the depth of the lesion (chondral versus subchondral), 
the size, and the location of the defect (Baghaban Eslaminejad et Malakooty Poor, 2014). 
The clinical classification systems are based on the morphological gross appearance of 
the defect. Outerbridge described four grades of cartilage damage in chondromalacia, 
with grade I for softening of the surface, grade II for fissuring without reaching the 
subchondral bone, and grades III and IV for defects going to or beyond the subchondral 
plate and exposing bare bone (Nehrer et Minas, 2000; Beris et al., 2005). 
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With increasing interest in cartilage injuries and repair techniques, the International 
Cartilage Repair Society (ICRS) developed its own classification system (Visual 
Assessment Scale) to more accurately describe chondral defects (Mainil-Varlet et al., 
2010; Ozmeriç et al., 2014). ICRS grade I lesions include those that demonstrate softening 
or those with superficial fissures present. Grade II injuries describe defects that have a 
depth less than 50% of the tissue thickness. Defects that have a depth greater than 50% 
of the tissue thickness are designated as grade III, while ICRS grade IV lesions are those 
that are full thickness, extending to or through the subchondral bone plate (Strauss et al., 
2011). 
Concerning classification of haemophilic arthropathy, several systems have been 
developed to quantify and monitor the degree of haemophilic arthropathy based on 
clinical and radiological findings. The two most widely used systems based on 
conventional radiological findings are: a) the Petterson score, in which the joint disease 
is classified base on its stage of development; b) the Arnold–Hilgartner scale, in which 
the joint is scored based on a summation of radiological changes. Recently, magnetic 
resonance imaging (MRI) has been used as a more sensitive imaging technique that can 
detect changes that are not visualised by conventional radiographs, and several scoring 
methods using MRI have been proposed (Raffini et Manno, 2007). 
 
4.1 Partial-thickness defects 
The partial-thickness (or chondral) defects of AC resemble the clefts and fissures 
observed during the initial stages of OA (Fig. 8 A,B). Defects of this nature in mature 
tissue do not heal spontaneously (Zhang et al., 2009). This failure is thought to be due to 
the fact that they only damage AC but do not penetrate into the underlying subchondral 
bone, rendering the defect site inaccessible to blood cells, and progenitor cells of the bone 
marrow space. Thus, the defect site lacks fibrin clots and other self-healing responses. In 
mature tissue, a limited repair process take place in response to the trauma within the 
tissue immediately adjacent to the site of the defect. The nature of this repair response 
has been investigated and it has been observed that the cells adjacent to the wound 
margins undergo cell death. After twenty-four hours, however, there is an increase in cell 
proliferation or chondrocyte cluster formation. Concurrent with this proliferation is also 
an increase in matrix synthesis and catabolism. However, this response is short lived and 
there is failure to repair the defect. It has also been observed that cells can be induced to 
migrate from the synovia membrane and subsynovial space across the articular surface to 
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the lesion and, under the influence of growth factors, can fill the defect with a repair tissue 
(Hunziker, 2001). However, in the absence of a fibrin matrix and mitogenic factors, these 
‘synovial cells’ fail to fill the defect void due in part to the anti-adhesive properties of 
proteoglycans. Hence, is not only the absence of access to the bone marrow cells that 
prevents the repair of partial thickness defects, there are clearly other mechanisms 
involved that remain to be fully elucidated (Redman et al., 2005). 
 
4.2 Full-thickness defects 
Full-thickness (or osteochondral) defects penetrate the entire thickness of AC, beyond the 
calcified zone, and into the subchondral bone (Fig. 8 A,C). Unlike partial-thickness 
defects, these are accessible to mesenchymal progenitor cells, macrophages, and blood 
cells, all of which are involved in a spontaneous immune response and a healing process 
after injuries. Briefly, immediately following injury, the defect void is filled with a fibrin 
clot and trapped platelets in turn, release various bioactive factors (i.e., PDGF; TGF-β), 
that stimulate vascular invasion functional to promote following migration of 
undifferentiated mesenchymal progenitor cells into the fibrin clot (Steinert et al., 2007). 
Also an inflammatory response is activated. Next, mesenchymal stem cells (MSCs) from 
bone marrow migrate into the defect, gradually replacing the fibrin clot and completely 
filling the defect after one week. Many of these MSCs can differentiate into chondrocytes 
later, which secrete a proteoglycan-rich ECM and repair the damaged cartilage tissue. 
However, it has been observed that fibrous, not hyaline, tissues with weaker mechanical 
properties and higher permeability are formed in defect sites. Consequently, the 
spontaneous repair process in full-thickness defects is only transient and imperfect, and 
tissue degeneration eventually occurs. Hence, the cartilage tissue often becomes 
hypertrophic and is finally replaced by the progressive deposition of subchondral bone 
(Temenoff et Mikos, 2000; Steinert et al., 2007; Zhang et al., 2009). Repair of full-
thickness cartilage defects depends mainly on the patient age, defect size and location. 
Only small full-thickness defects are repaired by formation of hyaline cartilage 
(Baghaban Eslaminejad et Malakooty Poor, 2014). 
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Figure 8. (A) Schematic drawing demonstrating partial and full-thickness defects of articular cartilage. 
Arthroscopic image of a partial-thickness (B) and full thickness (C) joint defect. 
 
5. Current management of articular cartilage defects 
Given the debilitating nature of severe joint pain, scientists and surgeons have tried for 
decades to repair or regenerate lost cartilage, but there has been little success due to the 
complex properties of the tissue and its essential function in the body (Temenoff et Mikos 
2000). The management of AC defects continues to be one of the most challenging 
clinical problems for orthopaedic surgeons (Bedi et al., 2010; Baghaban Eslaminejad et 
Malakooty Poor, 2014).  
Actually, cartilage repair strategies include: a) conservative/palliative treatments; b) 
surgical treatments (Neherer et Minas 2000) (Fig. 9).  
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Figure 9. Principles of the management of osteoarthritis. Suggested sequential, pyramidal approach to 
disease management (Dieppe et Lohmander, 2005). 
 
5.1 Conservative treatments 
Palliative options focus on the relief of mechanical symptoms in the cartilage injured 
patient (Williams et Brophy 2008). In the early phase of a chronic, symptomatic cartilage 
defect, conservative measures can be helpful. Nonsteroidal anti-inﬂammatory drugs can 
calm the inﬂammatory response of activated cartilage damage as well as intra-articularly 
administered corticosteroids. In addition, physiotherapeutic modalities (i.e., ultrasound, 
iontophoresis, thermal therapies) can decrease the symptoms of cartilage damage. The 
intra-articular application of hyaluronate provides lubrication of the joint surface and can 
improve joint function (Neherer et Minas 2000). 
Despite palliative options are used clinically to reduce pain and maintain joint movement, 
in many cases, surgical approaches are necessary. 
 
5.2 Surgical treatments 
A variety of surgical techniques has been developed to reduce joint pain, improve joint 
function and delay the onset of OA (Bark et al., 2014). In particular, these treatments can 
be classified into: repair, reconstruction and regeneration techniques (Vaquero et Forriol 
, 2012).  
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5.2.1 Repair tecniques 
The repair methods help to form fibrocartilaginous tissue, thereby facilitating the access 
of blood vessels and of osteoprogenitor cells that are capable of achieving 
chondrogenesis. These techniques include: a) arthroscopic lavage and debridment; b) 
stimulation of the bone marrow. 
a) Arthroscopic lavage and debridment 
Arthroscopic lavage involves the visually guided introduction and removal of saline 
solution into the knee joint to “washout” any excess fluid and loose bodies. In 
comparison, debridement may include the introduction of saline into the joint, in addition 
to the smoothening of bone surface without any further intervention, or in combination 
with other procedures such as abrasion, partial or full meniscectomy, synovectomy, or 
osteotomy (Health Quality Ontario, 2005) (Fig. 10). The cleaning process may relieve 
symptoms, but effects are temporary (Vaquero et Forriol , 2012). 
 
 
Figure 10. Cartilage repair technique through arthroscopic debridment.  
 
b) Stimulation of the bone marrow 
These systems are intended to stimulate cell migration and cytokine expression to repair 
the cartilage. They include Pridie perforations, abrasion using a burr as far as the bleeding 
subchondral bone, and microfractures. Bone marrow stimulation is the most frequently 
used technique for treating small symptomatic lesions of the AC in the knee. This 
technique involves perforation of the subchondral plate in order to recruit MSCs from the 
bone marrow space into the lesion. MSCs are able to differentiate into ﬁbro-chondrocytes, 
which contribute to ﬁbrocartilage repair of the lesion (Fig. 11). However, the overall 
concentration of the MSCs is quite low and declines with age. The formation of a stable 
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blood clot that maximally ﬁlls the chondral defect is important and it has been correlated 
with the success of bone marrow stimulation procedures (Bedi et al., 2010).  
 
 
Figure 11. Steps of the microfracture technique. (A) Damaged cartilage is removed; (B) Awl is used to 
make holes in the subchondral bone; (C) Healing response brings new, healthy cartilage cells. 
(D) Microfracture in human patients. 
 
5.2.2 Reconstruction methods 
Reconstruction methods are intended to fill the injury with autologous AC transplantation 
or allografts by arthroscopy or a mini-arthrotomy approach. These techniques include: a) 
mosaicplasty; b) osteochondral allografts; c) synthetic plugs. 
a) Autologous osteochondral grafts (mosaicplasty) 
Autologous osteochondral mosaic transplantation technique is one of the recently evolved 
methods to create hyaline or hyaline-like repair tissue in the pathologic area (Bartha et 
al., 2006). It consists in transplantation of multiple, small-sized, cylindrical osteochondral 
grafts harvested from the relatively less weight bearing periphery of the patellofemoral 
joint (Fig. 12). The transplanted hyaline cartilage should, in theory, survive the procedure 
and result in a more durable surface than that provided by fibrous repair tissue. Donor site 
repair by the natural healing processes should result in filling of the tunnels with 
cancellous bone and coverage of the surface with reparative fibrocartilage (Szerb et al., 
2005). 
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Figure 12. (A) Schematic drawing demonstrating the autologous osteochondral transplantation technique. 
A chisel can be used to harvest osteochondral plugs from the blue shades regions. (B) The donor region can 
be accessed through a small arthrotomy. (C) The recipient chondral defect with grafts in the desired 
configuration to fill the lesion (Bedi et al., 2010).  
 
b) Osteochondral allografts 
The advantage of allografts is that they are adaptable, as grafts can be designed for lesions 
of any shape or size, and they can be obtained from weight-bearing areas so that they are 
identical in form and curvature to the injured area. Moreover, they can be harvested 
without endangering the donor site. The disadvantage is that they have to be used in a 
short period of time, since they must be kept fresh in serum, and this is only possible for 
a few weeks after extraction, because cryopreserved cartilage is a matrix with few viable 
cells, and this affects the recovery of the cartilage morphology. There is also a risk of 
immune reactions and the transmission of disease (Vaquero et Forriol , 2012) (Fig. 13). 
 
 
Figure 13. (A) Harvesting of an osteochondral alograft dowel from a hemicondylar specimen with the size 
and radius of curvature matched to the recipient. (B) Implantation with circumferential flush contiguity at 
the recipient site for the treatment of an osteochondritis dissecans lesion of the femoral condyle. (C) 
Magnetic resonance image made at twenty-four months after implantation of the osteochondral allograft. 
There is excellent lesion fill and congruency with the adjacent native cartilage interface (Bedi et al., 2010).  
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c) Synthetic plugs 
Biphasic cylindrical scaffolds made of synthetic co-polymers greatly facilitate the 
techniques for filling osteochondral defects. The plug is designed to provide the benefits 
of marrow stimulation together with structural support to allow regeneration of AC to the 
same height as that of the surrounding articular surface. The advantage is that the right 
thickness and length can be chosen to fit the dimensions of the gap. In addition, such 
plugs can be combined with stem cells or growth factors (Vaquero et Forriol , 2012). 
 
5.2.3 Regenerative techniques 
Regenerative methods make use of bioengineering techniques to develop hyaline 
cartilage tissue. These techniques include: a) autologous chondrocytes implantation (Fig. 
14 A,B,C); b) matrix assisted chondrocytes implantation (Fig. 14 A,B,D). 
 
 
Figure 14. (A) A full-thickness focal chondral lesion. (B) The lesion is debrided to ensure healthy, stable 
margins for integration of the host tissue with the neotissue. (C) ACI. The debrided lesion is filled with 12–
48 million autologous chondrocytes and covered with a periosteal flap or mixed collagen type I and type 
III membrane. (D) MACI. The autologous chondrocyte population is expanded in vitro and then seeded 
onto an absorbable 3D (collagen types I and III or hyaluronic acid) matrix prior to implantation. The cell-
seeded scaffold is then secured into the lesion with fibrin glue.  
 
a) Autologous Chondrocytes Implantation (ACI) 
Biopsies of AC are taken from the low weight-bearing area of the patellofemoral joint 
and the autologous chondrocytes are harvested and expanded ex vivo for the re-
implantation into debrided areas of the damaged weight-bearing surface. Early surgical 
procedures using this technique involved the suturing of a periosteal flap over the 
transplanted cells to retain them at the site of implant (Fig. 15A); later, collagen 
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membranes replaced the periosteal flap to reduce operating time and complications 
involving graft hypertrophy (Oldershaw 2012; Chiang et Jiang, 2009) (Fig. 15 B). ACI 
has demonstrated significant and durable benefits for patients in terms of diminished pain 
and improved function. However, despite the promising clinical results, the use of ACI 
carries a number of limitations, essentially related to the complexity of the surgical 
procedure (Marlovits et al., 2006). 
 
 
Figure 15. ACI techique. Cells are retained in the site of implant with a periostal flap removed from the 
medial tibia (A) or with a collagen membrane (B). 
 
b) Matrix Assisted Chondrocytes Implantation (MACI) 
The first generation ACIs were associated with complications and problems due to 
cartilage hypertrophy and ossifications resulting from the use of periosteum. 
Subsequently, the second generation known as MACI introduced seeded membranes and 
biomaterials such as type I collagen, a matrix based on hyaluronic acid and type I/III 
collagen. Since this type of membranes were used, the hypertrophy was reduced to 5% of 
all cases, and the problems disappeared 3–6 months after the operation when the 
membrane was reabsorbed (Vaquero et Forriol , 2012) (Fig. 16). 
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Figure 16. Defect site before (A) and after (B) MACI. 
 
5.3 Management of haemophilic arthropathy 
In haemophilia, the aim of primary or secondary prophylaxis (depending on their onset, 
before or after joint damage) is to prevent recurrent bleeding into joints and the 
development of chronic arthropathy in later life. When started early, and at most after two 
joint bleeds, the result is predictably excellent if there is compliance with the primary 
prophylaxis regimen. Conversely, once joint damage has occurred, because of recurrent 
bleeding, secondary prophylaxis can only retard, but not prevent, ongoing joint damage 
(Van Den Berg et al., 2006). 
Treatment recommendations for patients who develop chronic synovitis and arthropathy 
should be made after careful consideration of all potential options. Conservative options 
aimed at minimising bleeding and/or controlling pain should be evaluated prior to surgical 
intervention (Raffini et Manno, 2007). 
The management of haemophilic arthropathy, which develops after repeated episodes of 
joint haemorrhage and accounts for the major morbidity in haemophilia provides for: a) 
physiotherapy; b) analgesia; c) synovectomy; d) steroid injections; e) hyaluronic acid 
injections; f) joint arthroplasty; g) arthrodesis; h) osteotomy. 
a) Physiotherapy 
Physiotherapy is an integral component of comprehensive haemophilia care and plays a 
role both in the prevention and treatment of joint disease (Astermark et al., 2014). 
Physiotherapy can be used acutely, after a haemarthrosis or surgery, as well as for patients 
with chronic synovitis or arthropathy. After a careful musculoskeletal assessment, 
treatment is individualised and often administered in conjunction with factor replacement. 
Goals of therapy include restoration or maintenance of range of motion, muscle 
strengthening, prevention or treatment of articular contracture, pain management, 
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increased exercise tolerance and improved balance and coordination (Raffini et Manno, 
2007). 
b) Analgesia 
Non-steroidal anti-inflammatory drugs (NSAIDs) are often used to treat arthritic pain in 
Non-Haemophilic patients. They act by inhibiting cyclooxgenase (COX) enzymes 
resulting in both an analgesic and anti inflammatory effect. This large class of drugs 
includes aspirin, traditional NSAIDS such as ibuprofen, and the newer selective COX-2 
inhibitors.  
Traditional NSAIDS are used sparingly in patients with bleeding disorders because of 
their anti-platelet effect and the concern for increased bleeding. Conversely, the use of 
COX-2 inhibitors seems to be effective as they do not interfere with platelet function 
(Rattray et al., 2006). Although narcotics may be effective, long-term use may lead to 
dependence (Raffini et Manno, 2007). 
c) Synovectomy 
Once a target joint has developed, it may be difficult to stop the cycle of repeated 
haemarthrosis with prophylactic clotting factor infusions (secondary prophylaxis). 
Patients who continue to bleed despite a trial of prophylaxis, and those in whom 
prophylaxis is not available or feasible, are candidates for interventions aimed at halting 
this cycle. Synovectomy, which entails excision or destruction of the friable synovium, 
is an approach that is frequently used to manage patients who experience recurrent 
haemarthrosis. This may be achieved by direct surgical excision during open or 
athroscopic synovectomy, or by injection of a radioactive or chemical agent that causes 
fibrosis or sclerosis of the synovium, also called synoviorthesis. Patients with advanced 
arthritic changes, severely narrowed joint space, decreased range of motion, and pain are 
less likely to benefit from synovectomy, and joint arthroplasty may be considered. 
There are many types of synovectomy: a) open synovectomy; b) arthroscopic 
synovectomy; c) Radionucleotide synoviectomy; d) chemical synovectomy (Raffini et 
Manno, 2007). 
d) Steroid injections 
Intra-articular injections of steroids have been used to transiently decrease pain and 
inflammation in patients with chronic synovitis, and may be useful as a palliative measure 
(Raffini et Manno, 2007). 
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e) Hyaluronic acid injections 
Hyaluronic acid has become an increasingly common agent for intra-articular injection 
for patients with osteoarthritis. Hyaluronic acid is a natural occurring viscous substance 
that is a fundamental component of the cartilage matrix. Intra-articular injection of this 
substance can improve pain in patients with arthritis, although its mechanism of action in 
not well understood. Improvements in pain or function after 3–5 injections in patients 
with haemophilic arthropathy have been reported in approximately 75% of patients 
(Raffini et Manno, 2007). 
f) Joint arthroplasty 
Patients with haemophilia who develop severe arthropathy may experience relentless 
pain, loss of motion and functional disability. If conservative management fails 
(analgesics, orthotics and physical therapy) these patients may benefit from total joint 
replacement. However, despite these improvements in pain and functional mobility, 
arthroplasty in haemophilia has been hampered by a high-complication rate. 
Complications include postoperative haemarthrosis, wound infection, joint sepsis and 
prothestic loosening. The frequency of these complications varies, but infection has been 
the single biggest problem. The long-term survival of joint replacement in haemophilia 
has been reported to be 90% at 5 years and 83% at 10 years. These outcomes are inferior 
to those observed in patients with osteoarthritis, in whom the 10–15 year prosthetic 
survival ranges from 90–95% (Raffini et Manno, 2007). 
g) Arthrodesis 
Arthrodesis is a procedure in which the synovium is removed and the joint is fused to 
prevent further motion. This approach, by its nature, reduces mobility but involves less 
extensive surgery and rehabilitation than joint replacement; it may be preferred for relief 
of pain in other joints for which joint replacement surgery is not routinely available 
(Raffini et Manno, 2007). 
h) Osteotomy 
Corrective osteotomy may be performed in patients with haemophilic joint disease and 
axial deformities, particularly around the hip, knee and ankle. While this may not restore 
range of motion, long-term results after osteotomy for haemophilic arthropathy of the 
knee showed improved pain in the majority of patients. This may be an option for patients 
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in whom joint replacement is not available or currently desirable (Raffini et Manno, 
2007). 
 
6. Tissue engineering: a novel approach 
To prevent progressive joint degeneration, surgical approaches are often the only option. 
However, in spite of total joint replacement success, other treatments for repair of 
cartilage damage are often inadequate, and rarely restore full function or return the tissue 
to its native normal state (Tuli et al., 2003; Mazor et al., 2014; Hubka et al., 2014). The 
lack of efficient modalities of treatment has prompted research on TE solutions (Mollon 
et al., 2013). Through this approach, regeneration of cartilage is pursued combining 
chondrogenic cells, scaffold materials and environmental factors to guide tissue 
formation (Getgood et al., 2009; Kim et al., 2011; Vinatier et al., 2009b) (Fig. 17). 
Autologous chondrocyte implantation yet discussed, represents one of the first TE 
applications for the regeneration of the AC surface. 
 
 
Figure 17. Requirements for cartilage tissue engineering. Cells, such as chondrocytes or mesenchymal stem 
cells, are expanded ex vivo and subsequently mixed with morphogens (growth and differentiation factors 
in hypoxic environment) on a 3D scaffold to initiate differentiation. The engineered scaffold will lead to 
cartilage formation after cells have differentiated, either after a period of ex vivo culture or after 
implantation in vivo (Vinatier et al., 2009b). 
  
6.1 Cell sources for cartilage engineering models 
The ideal cell source for cartilage TE is one that can easily be isolated and expanded, and 
which synthesizes abundant cartilage-specific ECM components, (i.e., aggrecan and type 
II collagen) (Johnstone et al., 2013). To date several cell sources have been investigated 
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as potential candidates (Nesic et al., 2006). However, the most interesting are 
chondrocytes and MSCs derived from a variety of tissues (Kock et al., 2012; Seo et al., 
2014). Chondrocytes are the native, differentiated cell type, and MSCs are the precursor 
or progenitor cells that possess the ability to differentiate into functional chondrocytes 
(Hubka et al., 2014).  
 
6.1.1 Differentiated chondrocytes 
Adult chondrocytes have been isolated from various sources like articular cartilage, ear 
cartilage, nasal septum, ribs. Among these, chondrocytes from hyaline cartilage have 
been considered the most obvious cell source. They are characterized by a rounded 
morphology and the production of ECM molecules such as type II collagen and sulfated 
glycosaminoglycans (GAGs) (Vinatier et al., 2009b; Kock et al., 2012; Hubka et al., 
2014). Moreover, differentiated chondrocytes maintain and remodel cartilage matrix 
tissue by a careful balance of catabolic and anabolic processes involving MMPs and tissue 
inhibitors of metalloproteinases (TIMPs).  
 
6.1.2 Mesenchimal stem cells 
Mesenchymal stem cells are multipotent progenitor cells. They exhibit vast mesodermal 
differentiation potentials able to give rise to osteocytes, adipocytes, chondrocytes, 
myoblasts, and tenocytes. In addition, they are able to differentiate into nerve cells and 
hepatocytes and can be considered as partly pluripotent (Kristjánsson et Honsawek, 
2014). MSCs are adult stem cells and, unlike embryonic stem cells, they do not show 
unlimited self-renewal capacity and cannot be maintained and expanded indefinitely in 
vitro. (Pelttari et al., 2008; Vinatier et al., 2009b). Under normal culture conditions, MSCs 
display a fibroblast-like morphology, are adherent to plastic, and can form colonies from 
single cells referred to as colony-forming fibroblast units. They display the surface 
antigens CD73, CD90, and CD105, while lacking the expression of the haematopoietic 
antigens CD11b, CD14, CD34, CD45, CD79, CD19, and HLA-DR (Kristjánsson et 
Honsawek, 2014). 
Recently, MSCs have been considered as an attractive source of cells for cartilage 
engineering (Pelttari et al., 2008; Vinatier et al., 2009b). Although they reside 
predominantly within the bone marrow, MSCs can be found in numerous tissues. In 
particular, MSCs isolated from adipose tissue, muscle (Adachi et al., 2002), periosteum 
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(Fukumoto et al., 2003) and synovium (Yokoyama et al., 2005) have been still 
investigated for cartilage TE approaches.  
 
6.2 Biomaterials in cartilage tissue engineering 
The use of matrix scaffolds in TE has paved the way for the use of functional tissue 
substitutes in the treatment of cartilage defects (Redman et al., 2005). Beyond 
biocompatibility, scaffolds intended for cartilage regeneration should fulfill many 
requirements, including adequate nutrient transport, adhesion to the defect site, minimally 
invasive implantation or injection, and degradability. Furthermore, one of the most 
important requirements is the ability to provide the proper mechanical function (i.e., 
compressive, shear, and tensile properties), either a priori or through directed tissue 
formation. Both synthetic and natural materials have been explored as potential scaffolds 
in a variety of forms, including hydrogels, sponges, and fibrous meshes, for cartilage 
regeneration. Of these various material structures, the most commonly explored are 
hydrogels, water-swollen networks crosslinked by either covalent or physical methods 
(Stoop, 2008; Kim et al., 2011). 
 
6.2.1 Synthetic materials 
Synthetic polymers have been widely used for TE since they are more controllable and 
predictable in mechanics and degradation rate than natural ones. Synthetic polymers 
currently explored for cartilage repair are: a) poly(α-hydroxy esters); b) Carbon fibres; c) 
Dacron and Teflon (Vinatier et al, 2009a). 
a) Poly(α-hydroxy esters) 
Polylactic acid (PLA) and polyglycolic acid (PGA) are derived from alpha 
hydroxypolyesters (Li et al., 2006); with their copolymers poly(lactic acid-co-glycolic 
acid) (PLGA) they are the most widely investigated for cartilage TE because of their 
biocompatibility and Food and Drug Administration approval for clinical application 
since 1990 (Lee et Shin 2007). PLA and PGA are degraded either by hydrolysis, or 
specific cleavage of oligopeptides. Their degradation products are however partially 
cytotoxic and these polymers induce important immunological reactions. Originally, they 
were developed to form resorbable suture wire (vicryl™) and medical devices (screw, 
plates). Since twenty years, they are tested alone or mixed with other matrices for 
cartilage TE. Various forms of these polymers, from the fine fibrillary layer to the sponge, 
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have been developed (Vinatier et al, 2009a). PGA polymers provide the best in vitro 
results, with a cellular density near of that found in vivo and a continuous production of 
type II collagen (Freed et al., 1993). 
b) Carbon fibres 
Carbon fibres are inert and therefore did not induce specific biological answer. They were 
used, without success, to fill rabbit cartilage defects in order to improve the spontaneous 
repair. The neo-tissue was fibrous and exhibited only weak mechanical properties. 
Despite these unsatisfactory results, carbon fibers have been applied in human with very 
variable results (Hunziker, 2002). 
c) Dacron and Teflon 
Dacron (polyethylene terephthalate) and Teflon (polytetrafluoroethylene) have been used 
to improve spontaneous repair of AC in rabbit. Results have reported the formation of a 
repair tissue, which was either a vascularized fibrous tissue or a fibrocartilage (Messner, 
1993). Due to an increased rigidity of joint after resurfacing with Teflon (Defrere et 
Franckart, 1992) and immunological reaction observed when these matrices was used as 
suture wires, these matrices seem not adequate. 
Unless specifically incorporated, synthetic polymers do not benefit from direct cell-
scaffold interactions, which can play a role in adhesion, cell signaling, directed 
degradation, and matrix remodelling. In addition, degradation by products may be toxic 
or elicit an inflammatory response. 
Among the synthetic biomaterials stands out Bio-Seed ®-C (BioTissue Technologies, 
Freiburg, Germany). It is a porous 3D scaffold made of polyglycolic acid (PGA), 
polylactic acid (PLA) and polydioxanone that has been seeded with autologous 
chondrocytes embedded within fibrin gel. Bio-Seed®-C has been reported to induce the 
formation of hyaline cartilage, which is associated with a significant clinical improvement 
of joint function (Vinatier et al., 2009b). 
 
6.2.2 Natural materials 
Natural materials used in cartilage TE can be classified as: a) protein-based scaffolds; b) 
carbohydrate-based scaffolds.  
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Protein-based scaffolds include collagen membranes or gels, fibrin glue (FG), and 
platelet-rich plasma (PRP), whereas, carbohydrate-based scaffolds include hyaluronic 
acid, alginate, agarose, and chitosan (Haleem et Chu, 2010).  
a) Protein based scaffolds 
i. Collagen 
Collagen-based membranes are among the mostly used matrices for cartilage engineering. 
Collagen is naturally degraded by collagenases and serines proteases and its degradation 
is controlled locally by the cells of the tissue. These collagen matrices implanted alone 
improve the spontaneous repair process of osteochondral defects in the rabbit. They are 
however generally associated with chondrocytes or MSCs (Vinatier et al., 2009a). 
ii. Fibrin 
Fibrin is a major component of blood clots. It can be used to adhere other engineered 
cartilage onto the recipient site, as a stand alone scaffold, or as a growth factor. Its utility 
is much limited by its inferior mechanical properties, the possibility of evoking immune 
and inflammatory responses, and its inability to allow host cells migration (Chiang et 
Jiang, 2009; Stoop et al., 2008). 
iii. Platelet Rich Plasma 
Recently, among blood derivatives, there has been a remarkable increase in the use of 
PRP to facilitate healing in a variety of pathological MSK conditions. The theoretical 
advantage of this autologous blood product rests in the concentrated platelets and 
associated quantity of platelet-derived growth factor and other mitogenic factors that may 
promote the healing of chondral injuries. PRP increases MSCs proliferation and 
chondrogenic differentiation but also proteoglycan and collagen production (Bedi et al., 
2010). 
b) Carbohydrate based-scaffold 
i. Hyaluronic acid 
Hyaluronic acid is a non-sulphated GAG that makes up a large proportion of cartilage 
ECM. In its unmodified form, it has a high biocompatibility and plays an important role 
in determining the biophysical microenvironment for chondrocyte growth and 
proliferation. Since unmodified hyaluronic acid does not possess sufficient mechanical 
strength, cross-linking by esterification has been used to optimise its biomechanical 
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properties. Matrices composed of hyaluronan have been frequently used as a carrier for 
chondrocytes or bone-marrow-derived MSCs (Stoop et al., 2008). 
ii. Chitosan, alginate and agarose 
Other naturally occurring polymers such as chitosan, alginate and agarose are extensively 
used in in vitro applications. However, their role in in vivo cartilage reconstruction is still 
very limited.  
Among natural materials, such products are still used in clinical practice. Membranes 
formed of type I and III collagens are clinically available for autologous chondrocyte 
implantation; such membranes include MACI® (Verigen, Lever-kusen, Germany), Maix® 
(Matricel, Hezoenrath,Germany) and Chondro-gide® (Geistlich Biomaterials,Wolhusen, 
Switzerland). This collagen gel enables the 3D culture and in vivo implantation of human 
autologous chondrocytes and of bone marrow MSCs. Of the polysaccharide-based 
biomaterials, Hyalograft® C, a tissue-engineered graft, consists of autologous 
chondrocytes that are associated with a hyaluronic-acid-based matrix termed HYAFF-
11® (Fidia Advanced Biopolymers, Abano Terme, Italy). This concept has shown a 
clinical improvement of cartilage function in humans (Vinatier et al., 2009b).  
 
6.2.3 ECM-based scaffolds 
One approach that has become very popular and appealing for tissue repair is the use of 
decellularized tissues. The principle of this technology involves decellularization of an 
allogenic or xenogenic homologous organ (to remove tissue antigenicity) followed by 
recellularization of the resultant three-dimensional scaffold with autologous stem and 
progenitor cells, which would hopefully assemble and organize into a structural and 
functional unit. The three-dimensional decellularized tissue consists exclusively of the 
component molecules of ECM, which provide cues that affect cell migration and 
proliferation. The use of ECM as a bioactive scaffold to promote functional tissue 
reconstruction has been used yet in many clinical applications including MSK repair 
(Faulk et al., 2014; van Osch, 2014). Because the native ECM guides organ development, 
repair and physiologic regeneration, it provides a promising alternative to synthetic 
scaffolds and a foundation for regenerative efforts (Song et Ott, 2011). 
Advantages of these materials are that many of them are natural bodily constituents that 
provide a natural adhesive surface for cells and carry the required information for their 
Introduction 
40 
 
activity. Moreover, their degradation products are physiological and therefore non-toxic 
(Vinatier et al., 2009b). 
 
6.2.4 Hydrogels 
Various polymers, including natural, synthetic and natural/synthetic hybrid polymers, 
have been used to make hydrogel scaffolds via chemical or physical crosslinking (Scotti 
et al., 2010). Hydrogels have been used as an important class of tissue-engineering 
scaffolds because they can provide a soft tissue-like environment for cell growth and 
allow diffusion of nutrients/cellular waste through the elastic hydrogel network (Zhu et 
Marchant, 2011). As they exhibit a high water content, close to that found in 3D-like 
ECMs , hydrogels are particularly useful in TE approaches especially for cartilage TE 
(Vinatier et al., 2009b; Seo et al., 2014). Moreover, they have advantages over other types 
of polymeric scaffolds, such as easy control of structural parameters, high water content, 
promising biocompatibility and adjustable scaffold architecture (Zhu et Marchant, 2011). 
In the field of tissue engineering, hydrogels have many different functions. They are 
applied as space filling agents, as delivery vehicles for bioactive molecules, and as three-
dimensional structures that organize cells and present stimuli to direct the formation of a 
desired tissue (Drury et Mooney, 2003).  
 
6.2.5 Polyvinyl alcohol 
Polyvinyl alcohol (PVA) is a semi-crystalline synthetic polymer produced by the partial 
or full hydrolysis of polyvinyl acetate (PVAc). The amount of hydroxylation determines 
the physical characteristics and chemical/mechanical properties of PVA (Baker et al., 
2012).  
Because of its excellent biocompatibility, low price, and easy processability, PVA has 
gained much attention over the past few decades for its biomedical and pharmaceutical 
applications as a matrix for TE and as a vehicle for controlled drug delivery. Aqueous 
PVA solutions can be chemically crosslinked through the formation of acetal linkages 
using difunctional crosslinking agents (i.e., formaldehyde and glutaraldehyde) or by 
electron beam or gamma irradiaton. However, it is well known that these solutions can 
be transformed into hydrogel even via crystallite formation from repeated freezing 
thawing cycles, without any chemical crosslinkers that may lead to toxicity. Briefly, 
during exposure to cold temperatures water freezes, expelling PVA and forming regions 
of high PVA concentration. As the PVA chains come into close contact with each other, 
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crystallite formation and hydrogen bonding occur. These interactions remain intact 
following thawing and create a non-degradable three-dimensional hydrogel network (Fig. 
18). By increasing the number of freeze–thaw cycles and modulating temperature ranges, 
the degree of polymer phase separation, crystallite formation, and hydrogen bonding can 
be increased (Holloway et al., 2011; Spiller et al., 2011). Hence, hydrogel mechanical 
properties can thus be tailored (Kim et al., 2015).  
 
 
Figure 18. Schematic diagrams showing the mechanisms for (A) hydrogel formation of PVA solution by 
a freezing–thawing method (Kim et al., 2015). 
 
Polyvinyl alcohol hydrogels have been extensively investigated as artificial AC (Grant et 
al., 2006). Values of compressive modulus, shear modulus, tensile modulus, and 
permeability were similar (Spiller et al., 2011), making these hydrogels attractive 
biomaterials for cartilage TE applications (Holloway et al., 2011). SaluCartilage™ 
(Salumedica, Smyrna, GA); Cartiva™ (Fig. 19), Cartiva SCI™ (Carticept Medical, Inc) 
are PVA devices that has been designed to mimic natural cartilage and still used in clinical 
to repair focal cartilage defects and osteoarthritic joints, while minimizing the resection 
of healthy tissue. 
 
 
Figure 19. Cartiva™ implat before (A) and after (B,C) implantation. 
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6.3 Chondrogenic factors in cartilage engineering 
A number of growth and differentiation factors that regulate cartilage development and 
homeostasis of mature AC have been identified. The most characterized factors which 
stimulate the anabolic activity in cartilage include members of Transforming Growth 
Factor (TGF)-β superfamily, Bone Morphogenetic Protein (BMP), Fibroblast Growth 
Factors (FGF), Insulin Growth factor (IGF)-1, Hedgehog (hh) and Wingless (Wnt) 
proteins (Vinatier et al., 2009a; Demoor et al., 2014). 
 
7. Engineering of articular cartilage: three approaches 
There are three possible approaches to the engineering of articular cartilage. According 
to the first, the repair tissue is engineered completely in vitro, the fully-differentiated 
construct being then implanted within the defect void. The advantage of this approach is 
that cell metabolism and differentiation are subject to better control in vitro than in vivo, 
if the appropriate bioreactor systems, growth factors and delivery systems are available. 
Its drawbacks are that the problems associated with the integration and the mechanical 
fixation of the repair tissue cannot be readily anticipated and solved. Moreover, the 
simulated mechanical-loading conditions of the ECM may not be ideally suited to the 
specific needs of the prospective repair site. In addition, biocompatibility and 
immunological problems are frequently associated even with this in vitro approach and 
in the absence of a scaffold. Furthermore, the natural curvature of the joint surface poses 
a challenge to the process of press-fitment whereby the engineered construct is introduced 
into the defect void. 
The second approach, which is more frequently adopted, aims to engineer only the basic 
building block: a matrix scaffold containing a homogeneous population of cells, and 
signalling molecules that are entrapped within an appropriate delivery system. The 
vehicle-bound signalling molecules ensure that the desired differentiation process takes 
place in vivo and that chondrocytic activity within the repair tissue is sustained. According 
to this approach, the differentiation and the remodelling of the repair tissue occur in vivo 
under physiological conditions of mechanical loading. Repair tissue that is formed in situ 
is more likely to adhere to and integrate with native AC than is that produced in vitro, and 
it will also adapt naturally to the contour of the synovial joint, provided that appropriate 
measures are taken to promote the bonding of the implant that has been generated in 
culture. One of the disadvantages of this second approach is that cell activity is more 
difficult to control on a long-term basis. Moreover, appropriate measures must be taken 
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to avoid “contamination” from cells and signalling substances that are involved in the 
spontaneous healing response, since the tissue thereby formed would compromise the 
quality and the mechanical competence of the final repair-composite. 
The third approach involves the direct application of exogenous growth factors 
(entrapped within a matrix) to the defect site; these then stimulate the intrinsic formation 
of cartilaginous tissue in situ. An appropriate matrix is first introduced into the defect to 
define the space that is to be repaired. The laying of this physical “track” is necessary to 
guide the movements of the intrinsic precursor cells, which have a limited spatial 
awareness. The growth factors are usually introduced into the matrix in two different 
states: as a freely-soluble agent, to stimulate the immediate recruitment, migration and 
proliferation of the precursor cells from their site of origin into the defect area; and in a 
vehicle bound form, for gradual delivery at a steady rate that is sustained for several 
weeks to stimulate the chondrogenic differentiation of the defect filling population of 
cells. Hence, an intelligent, internally-programmed matrix is applied to the defect. The 
freely-soluble signalling agent usually applied are IGF-1, bFGF or a TGF-b (at low 
concentration) (Hunziker et al., 2014). 
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AIM OF THE STUDY 
 
 
Cartilage degeneration is the hallmark of osteoarthritis. Amongst musculoskeletal 
disorders, osteoarthritis is the most common joint disease and is recognized as a major 
cause of pain and disability. It develops most commonly in the absence of a known cause 
of joint degeneration, a condition referred to as primary or idiopathic osteoarthritis. 
Beyond non-surgical conservative options, which can only provide symptomatic relief, 
osteoarthritic patients can take advantage from a large variety of surgical treatments that 
have been developed to reduce joint pain, improve joint function and delay the onset of 
osteoarthritis, sustaining cartilage recovery. Among these, TE approaches stand out (i.e. 
ACI, MACI). However, despite the promising clinical results, they still carries a number 
of limitations.  
Less frequently, osteoarthritis develops as a result of joint degeneration caused by injuries 
or a variety of hereditary, inflammatory, or developmental, metabolic, and neurologic 
disorders, a group of conditions referred to as secondary osteoarthritis. A hereditary rare 
bleeding disorder, that is haemophilia, is characterized by recurrent haemarthroses that 
determine progressive cartilage damage leading to haemophilic arthropathy. In patients 
with haemophilia, current available orthopaedic strategies can only slow the progression 
of joint damage resulting in lesions that tend to be more extensive than focal. Arthroplasty 
becomes the only resolute option; however, it can results in a hospital stay painful and in 
several complications ranging from anemia, inhibitor development, anaphylactic 
reactions, haematomas and haemarthroses, up to infections. Interestingly to our purposes, 
any approach aims to promote cartilage recovery in haemophilics, at least in the early 
stages of cartilage damage. 
Due to cartilage low self-ability repair, AC restoration represents a challenge of 
musculoskeletal TE. In fact, the employ of matrix scaffolds has paved the way for the use 
of functional tissue substitutes in the treatment of cartilage defects. Beyond 
biocompatibility, scaffolds intended for cartilage regeneration should fulfill many 
requirements, including adequate nutrient transport, minimally invasive implantation or 
injection, and degradability (Stoop, 2008).  
Hydrogels have been used extensively in the field of TE, because they can provide a soft 
tissue-like environment. Among these, a synthetic polymer still used in orthopaedic 
surgery, is polyvinyl alcohol. In virtue of its ability in mimicking cartilage tissue, it has 
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gained a wide attention. However, it is employed merely as non- biodegradable 
prosthesis. 
Established that, this work focused on polyvinyl alcohol, providing to: 
i. chemically modify and characterize a novel synthetic polymer polyvinyl alcohol-
based; 
ii. manufacture and characterize for physico-mechanical properties, 
biocompatibility, biodegradation rate, loading ability, physically cross-linked 
scaffolds realized using chemically modified polymer solutions; 
iii. promote scaffold ability in sustaining cell adhesion and proliferation through the 
development of a composite scaffold. This will be obtained combining chemically 
modified polyvinyl alcohol and a biological decellularized tissue from umbilical 
cord in comparison with AC extracellular matrix; 
iv. isolate articular chondrocytes from cartilage of haemophilic patients and 
characterize them for their morphology, expression of specific m-RNA, 
immunophenotype in comparison with chondrocytes isolated from AC of Non-
Haemophilic patients. Will be verified the chance of using them in tissue 
engineering approaches in the perspective of autologous implant;  
v. verify composite scaffold ability in sustaining cell adhesion and proliferation 
assessing eventual differences among Haemophilic and Non-Haemophilic 
chondrocytes. 
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1. Preparation of polymer solutions  
1.1 PVA solution 
PVA solution was obtained suspending in MilliQ water (MilliQ Academic system, 
Millipore, Bedford, MA, USA) a pre-weighted quantity of PVA powder (Molecular 
weight (Mw.) 146,000-186,000 Da, 99+% hydrolyzed) (Sigma-Aldrich Chemical 
Company, St. Louis, MO, USA) (16% w/w solution). Powder suspension was than heated 
for 48 hours (h) at 100 °C, under stirring, until polymer was completely dissolved.  
 
1.2 Oxidized PVA solutions 
PVA oxidation was performed in 4 stages described below. 
a) PVA dissolution. 
A pre-weighted quantity of PVA powder (Mw. 146,000-186,000 Da, 99+% hydrolyzed) 
was suspended in MilliQ water (16% w/w solution). Powder suspension was than heated 
for 48 hours (h) at 100 °C, under stirring, until polymer was completely dissolved.  
b) Preparation of oxidant solution.  
Partial oxidation of PVA was obtained using potassium permanganate (KMnO₄) (Fluka, 
Basel, Switzerland ) in diluted perchloric acid (HClO₄) (Fluka).  
The required amount of KMnO4, in the ratio of 10 mg salt per ml of water, was weighed 
accurately and dissolved in deionized water under stirring. The environment was acidified 
by addition of HClO4 at 70%. 
c) Oxidation of PVA.  
The oxidant mixture was poured rapidly in PVA solution, stirred vigorously, and allowed 
to react in a thermostatic bath at 30 °C until complete discoloration of the polymer 
solution. Discoloration occurred in about 60 min. 
d) Dialysis against deionized water. 
Oxidized solution was poured in a membrane with 8,000 Da cut-off (SpectraPor, 
Philadelphia, PA, USA) and dialyzed extensively against deionized water under stirring 
for 48h. Water was replaced every 6 h.  
Materials and Methods 
48 
 
For our purposes, were prepared PVA solutions with an oxidation degree of 1% and 2% 
respectively. 
Typically, to prepare 1% oxidized (1% Ox) PVA, one gram of PVA was solubilized in 
20 ml of MilliQ water and then 5 ml of KMnO₄ water solution [2.9 mg/ml] and 0.3 ml of 
70% HClO₄ were added.  
To prepare 2% oxidized (2% Ox) PVA, the amounts of KMnO₄ and HClO₄ were doubled.  
The stoichiometry of the reaction is described by the following equation, referred to a 
hypothetical vinyl alcohol monomer (- CH₂ CHOH -): 
 
2KMnO4 + 5[CH2 CHOH] + 6HClO4 → 5[CH2 CO] + 2 Mn(ClO4)2 + 8H₂O + 2KClO4 
 
2. Oxidized polymer solutions characterization 
2.1 2,4-Dinitrophenylhydrazine assay. 
Highly sensitive assay for detection of carbonyls (aldehydes and ketones) involve 
derivatisation of the carbonyl group with 2,4-dinitrophenylhydrazine (DNPH) leading to 
the formation of a stable 2,4-dinitrophenyl (DNP) hydrazone product (Fig. 20). 
Derivatisation with DNPH is typically developed in solutions of 2 M hydrochloric acid 
(HCl) (Carlo Erba, Milan, Italy).  
 
 
Figure 20. Mechanism for the reaction between 2,4-dinitrophenylhydrazine and carbonyl group of an 
aldehyde or ketone. 
 
The classical approach involves carbonyl groups reaction with DNPH, followed by the 
spectrophotometric quantification of the acid hydrazones at 375 nm. It absorbs ultraviolet 
light so that the total carbonyl content can be quantified by a spectrophotometric assay; 
however, to give greater sensitivity and specificity, it can be coupled to fractionation by 
high-performance liquid chromatography (HPLC). Gel-filtration chromatography 
(GPC) by HPLC has proved to be a convenient and efficient technique in which DNP-
carbonyl derivatives are separated by molecular weight, allowing a more specific 
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analysis of carbonyl content. HPLC spectrophotometric detectors are also far more 
sensitive than stand-alone spectrophotometers; so much less sample is required for 
quantitation of carbonyl content. The quantitative derivatisation requires that a large 
excess of reagent be present, and reagent removal to allow spectrophotometric 
determination of the protein-bound hydrazone. 
 
2.1.1 Quantification of oxidized PVAs carbonyls 
2,4-Dinitrophenylhydrazine assay has been performed to quantify the oxidative 
modification of PVA backbone. Briefly, 10 mg of lyophilized 1% and 2% oxidized PVA 
were dissolved at 100°C in 1 ml of MilliQ water respectively. One-hundred microliters 
of these solutions were added to 900 µl of 10 mM DNPH (Fluka) solution in HCl 2.5 M. 
The PVA-phenylhydrazone derivative reached maximum yield after 48 h at 25°C and it 
was recovered by GPC on a PD-10 column (GE Healthcare, Cleveland, OH, USA). 
Mobile phase consisted of 70/30 (v/v) Phosphate Buffered Saline (PBS) (Gibco, 
Invitrogen Corporation, Paisley, UK) and methanol (Fluka) at 1 ml/min flow rate. The 
separation profile was monitored at 375 nm. The first eluted peak corresponded to 
hydrazones bound to PVA; it was collected and the absorption spectrum was registered 
using a spectrophotometer Jasco mod V630 (Jasco Corporation, Great Dunmow, Essex, 
GB). The amount of phenylhydrazone derivatives was evaluated from the absorbance (A) 
at 375 nm taking into account a molar absorbtivity (ε) of 22,000 (M x cm-1). 
 
2.2 Reductive amination. 
Reductive amination is a selective and versatile technique to alkylate amines. It is 
accomplished by treating the protein with a simple aliphatic aldehyde or ketone and a 
reducing agent, usually sodium borohydride or sodium cyanoborohydride (which is more 
selective). It consists of two subsequent reactions: 
 
a. condensation of an amine with an aldehyde/ketone to an imine, with abstraction 
of water 
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b. reduction of the imine to the corresponding amine 
 
 
 
2.2.1 Covalent binding of lysozyme 
The covalent interaction between oxidized PVA and lysozyme (Sigma-Aldrich) was 
evaluated using the reducing agent sodium cyanoborohydride (NaBH3(CN)) (Sigma-
Aldrich). Twenty mg/ml of 1% Ox and 2% Ox PVA solutions were incubated with a 
lysozyme solution in PBS [13 mg/ml], at RT, in presence of NaBH3(CN) [2.5 mg/ml]. At 
different end-points (4, 24, 50, 120 h) the solutions were analyzed by GPC using a high 
performance column Superose 6 10/300 GL and an HPLC AKTA (GE HealthCare, Little 
Chalfont, Buckinghamshire, UK). The absorption profiles of bound and free lysozyme 
were monitored at 280 nm with PBS as eluent and a flow rate of 0.5 ml/min. 
 
3. Scaffold manufacture.  
PVA, 1% and 2% oxidized PVA were used to prepare scaffolds by pouring solution of 
each between two plate glasses detached by spacers (2 mm). Physical cross-linking of 
polymer solutions occurred through a partially modified FT process according to 
Lozinsky (Lozinsky et al., 1995). Briefly, polymeric aqueous solutions cast into molds 
were exposed to FT: one cycle consisted in a freezing period (at -20°C) followed by a 
thawing one (at -2.5°C). Each period lasted 24 h; three cycles occurred. 
 
4. Scaffold characterization 
4.1 Morphological analysis by Scanning Electron Microscopy analysis. 
Morphological analysis of PVA, 1% and 2% oxidized PVA scaffolds was performed by 
SEM. Samples were dehydrated by immersion in increasing concentrated alcohols (30% 
- 100%) (1h /alcohol) (Sigma-Aldrich). Hydrogels were then exposed to Critical Point 
Drying and gold sputtered and finally observed. Images were taken with a Stereoscan-
205 S scanning electron microscope (Cambridge instruments, Pine Brook, NJ, USA) of 
CUGAS, Interdepartmental Service Centre at University of Padua. 
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4.2 Mechanical behavior and physical properties. 
4.1.1 Stress-strain tests  
Resilience is a measure a material’s ability to deform reversibly without energy loss. To 
evaluate the chance of using oxidized PVAs as mechanical support for cartilage 
regeneration, the resilience of chemically modified hydrogels was assessed in comparison 
to the neat polymer and to human AC tissues.  
Five samples of neat PVA, 1% and 2% Ox PVA hydrogels were cut from cross-linked 
polymer sheets into strips (5 x 25 x 0,3 mm3, n = 5). In parallel, isometric samples were 
obtained from human AC specimens (5 x 25 x 0,3 mm3, n = 3). Hydrogels were evaluated 
both dried and swelled, after 24 h in PBS at 37 °C to simulate the exposure to body fluids. 
The strips were clamped with tensile grips between opposing motors for stress-strain tests 
using a universal testing machine Bose® ElectroForce® TestBench system (Bose 
Corporation, Eden Prairie, Minnesota, USA) with an extended stroke actuator. The 
system was equipped with a 22 N load cell and tests were carried out at room temperature 
by subjecting each sample to a maximum elongation of 100% of the initial length (from 
5 mm to 10 mm) with a strain rate of 0.5 mm/s. This parameter is of major importance: it 
can affect the measure because of the viscoelasticity of the samples. To minimize any 
viscoelastic effect, high strain rate is usually applied. 
The load cell measured the force applied during consecutive loading/unloading cycles.  
The instrument used is located at Department of Industrial Engineering, University of 
Padua. Data were collected with the WinTest® Controls software (Bose Corporation) and 
analyzed with Origin Pro 9.1 (Northampton, Massachusetts, USA). 
 
4.1.2 Dynamic Light Scattering  
Dynamic Light Scattering (DLS), also called Photon Correlation Spectroscopy, is a 
spectroscopic technique that indirectly determines particles size and size distribution of 
polymers, proteins and colloids by measuring their speed as they move in suspension.  
Small particles in suspension undergo random thermal motion known as Brownian 
motion. This random motion is modeled by the Stokes-Einstein equation:  
 
Dh = 
kBT
3πDt
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where Dh is the hydrodynamic diameter; Dt is the translational diffusion coefficient; kB 
is the Boltzmann’s constant; T is the thermodynamic temperature; π is the dynamic 
viscosity. 
Stokes-Einstein equation connects diffusion coefficient measured by dynamic light 
scattering to particle size. 
Shining a monochromatic light beam, such as a laser, onto a solution with spherical 
particles in Brownian motion causes a Doppler Shift when the light hits the moving 
particle, changing the wavelength of the incoming light. This change is related to the size 
of the particle. It is possible to compute the sphere size distribution and give a description 
of the particle’s motion in the medium, measuring the diffusion coefficient of the particle 
and using the autocorrelation function. 
Although the fundamental size distribution generated by DLS is an intensity distribution, 
this can be converted, using Mie theory, to a volume distribution or a distribution 
describing the relative proportion of multiple components in the sample based on their 
mass or volume rather than based on their scattering (Intensity).  
Average size and dispersion of neat PVA, 1% Ox and 2% Ox PVA micelles in water was 
evaluated by DLS using a Zetasizer Nano-ZS DLS instrument (Malven Instruments Ltd., 
Worcestershire, UK), under the control of a Peltier unit at 25 °C. Solutions containing 3 
mg/ml of each sample were centrifuged at 22°C at 15,000 rpm for 1 h in a GS-15R 
centrifuge (Beckman, Brea, CA). A volume of 150 µl of each supernatant was analyzed; 
volume plots were used. The refraction indices considered were that of polystyrene and 
water for PVA and the dispersing medium, respectively. 
 
4.1.3 Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) is a thermal analysis technique used to measure 
enthalpy changes due to changes in the physical and chemical properties of a material as 
a function of temperature. In a DSC the difference in heat flow to the sample and a 
reference at the same temperature, is recorded as a function of temperature. The reference 
is an inert material such as alumina, or just an empty aluminium pan. The temperature of 
both the sample and reference are increased at a constant rate. Since the DSC is at constant 
pressure, heat flow is equivalent to enthalpy changes. The heat flow difference between 
the sample and the reference can be either positive or negative. In an endothermic process, 
such as most phase transitions, heat is absorbed and, therefore, heat flow to the sample is 
higher than that to the reference. Hence enthalpy is positive. In an exothermic process, 
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such as crystallization, some cross-linking processes, oxidation reactions, and some 
decomposition reactions, the opposite is true and enthalpy is negative. 
Thermal characteristics of PVA scaffolds were assessed by means of Differential 
Scanning Calorimetry DSC 200 PC (Netzsch-Gerätebau GmbH, Selb, Germany). 
Samples were firstly air-dried for 24 h, about 10 mg were then placed in an aluminum 
pan and heated at a scanning rate of 10 °C/min up to 250 °C. Measurements were carried 
out in nitrogen atmosphere. Melting temperature (Tm) and enthalpy (ΔHm) were evaluated 
from the first heating scan; the crystallinity degree was calculated from the melting 
enthalpy as follows: 
0
.100mc
H
X
H



 
where ΔH0 is the melting enthalpy of 100% crystalline PVA (138.6 J/g) (Hassan et 
Peppas, 2000). 
 
4.1.4 Swelling behavior 
Immersed in an aqueous solution, a network of covalently cross-linked polymers imbibes 
the solution and swells, resulting in a hydrogel. The amount of swelling is affected by: 
mechanical forces, pH, salt, temperature, light, and electric field. 
PVA and oxidized PVA hydrogels (5 x 2 x 30 mm) were separately immersed in 5 ml of 
PBS 1X solution 37 °C and 95% relative humidity for a total amount of 600 h. Every 24 
h, PBS excess was removed by wiping hydrogels with filter paper and samples were 
weighed. The swelling ratio was calculated by the following equation: 
Swelling (%)= 
(Ws-Wd)
Wd
 ∙100 
where Ws is the weight of the swollen hydrogel and Wd is the weight of the dry hydrogel 
(Del Gaudio et al., 2013). 
 
5. Oxidized polyvinyl alcohol scaffolds as drug carrier 
5.1 Bovine serum albumin adsorption and release 
 Protein release ability of PVA, 1% Ox and 2% Ox PVA scaffolds (7 mm diameter x 2 
mm thickness) was investigated using Bovine Serum Albumin (BSA) (Mw. 66.5 kDa) 
(Sigma-Aldrich) as protein model. Scaffolds were soaked in 1 ml of BSA solution in PBS 
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[40 mg/ml] for 24 h at 37 °C (pH 7.4). After the incubation period, each scaffold was 
transferred in 1 ml of fresh PBS which was collected and changed at predetermined end-
points: 1, 24, 144 h. The absorption at 280 nm of washing solutions was recorded and the 
content of BSA was evaluated ( = 0.66). The resulting data were normalized considering 
scaffolds weight after lyophilization.  
 
5.2 TGF-β1 absorption and release 
PVA supports were incubated in 1ml of TGF-β1 (Mw. 25 kDa) (Sigma-Aldrich) [50 
ng/ml] in PBS for 48 h at 37 °C. Growth factor release at 24, 48 and 72 h was detected 
using a fluorimeter Jasco FP-6500 (Jasco Corporation). The spectra were recorded using 
a Suprasyl quartz cuvette with excitation and emission optical paths of 10 mm and 2 mm, 
respectively. Excitation wavelength was set at 280 nm, while emission spectra were 
acquired in the range between 290 and 450 nm.  
 
5.2.1 Evaluation of TGF-β1 release on human primary chondrocytes.  
The effect of TGF-β1 release from PVA and oxidized scaffolds was evaluated on a human 
articular chondrocyte (AC) population. Cells were isolated, cultured, and characterized 
as we described previously (Stocco et al., 2014). A 600 μl suspension of ACs at passage 
2 was seeded in one well of a 24-multiwell plate (10,000 cells/ cm2) and a culture plate 
insert (cut-off, 1µm) (BD-Falcon, USA) was placed in. PVA and oxidized PVA scaffolds 
were then introduced into inserts and soaked in 400 µl of complete medium. After 72 
hours and 7 days from seeding, cell proliferation was evaluated by 3-(4,5-
dimethylthiazol-2-yl)-2,5-dimethyltetrazolium bromide (MTT) assay.  
MTT is a yellowish solution which is converted to water-insoluble MTT-formazan of 
dark blue color by mitochondrial dehydrogenases of living cells. The blue crystals are 
soluble with acidified isopropanol and the intensity can be measured colorimetrically at 
a wavelength of 570 nm.  
At the end points considered, once inserts with scaffolds were removed, wells were 
washed gently with PBS. After taking out the buffer, cells were treated with 500 µl of 
MTT (0.5 mg/ml) in basal medium for 4 h at 37 °C in humidified atmosphere containing 
5% CO2. Afterwards, MTT solution was removed and formazan precipitates were 
dissolved in 300 µl of 2-propanol acid (0.04 M HCl in 2-propanol) (Sigma-Aldrich). 
Dissolution occurred placing the 24 well plates on a tilting shaker (Asal, Milano, Italy) 
for 20 min at RT. Dissolved formazan precipitates were collected carefully and moved to 
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a 96 well plates. Optical density was measured at 570 nm, using a Microplate autoreader 
EL 13 (BIO-TEK instruments Inc., Winooski, Vermont USA). Results were expressed as 
number of cells grown on seeded surface. 
 
6. In vivo study on scaffold biodegradability.  
All animal procedures were approved by the ethical committee of Padua University, 
following the guidelines established by the National Institutes of Health. Animals were 
housed in a temperature-controlled facility, and were given laboratory rodent diet and 
water ad libitum. Twelve BALB/c mice were gas anesthetized by isoflurane and oxygen 
administration. The dorsa of the animals were shaved and sterile prepped with Betadine® 
(Bayer, Leverkusen, DE). A lombotomic incision of about 20 mm was performed on the 
right side of the dorsum using a N°. 10 surgical blade (Becton-Dickinson, Franklin Lakes, 
NJ, USA). A subcutaneous pouch was created using blunt dissection technique and 
polymers disks (7 mm diameter x 2 mm thickness) of PVA, 1% Ox and 2% Ox PVA (n=4 
each group) were inserted in, and anchored to the latissimus dorsi muscle using TYCRON 
4/0 sutures. Following implantation, the skin was stitched up using absorbable 
NOVOSYN 4/0 sutures. After surgery, animals were administered anti-inflammatory 
(Rimadil, 5 mg/kg) and antibiotic (Bytril, 5 mg/kg) therapy for 5 days and were allowed 
to recover in the cage. Twelve weeks from implantation, mice were euthanized by carbon 
dioxide asphyxiation. Implants and surrounding tissues were excised and scaffolds were 
preliminary analysed for their size and integrity, compared to not implanted controls. 
Moreover, samples were fixed with 2.5 % glutaraldehyde in 0.1 M cacodylate buffer (pH 
7.2) (Sigma-Aldrich) for SEM investigation. Samples for histological and 
immunohistochemical analysis were frozen and included in OCT or fixed in 10% 
formalin solution in neutral PBS (Sigma-Aldrich)and embedded in paraffin. 
 
6.1 Histological analysis of explanted samples  
Samples included in OCT were cut into 10 µm-thick serial sections and stained with 
Haematoxylin-Eosin (Bio-Optica, Milano, Italy). They were mainly used for evaluation 
of PVA characteristics and state of degradation.  
Haematoxylin has a deep blue-purple colour and stains nucleic acids. Eosin is pink and 
stains proteins non-specifically. In a typical tissue, nuclei are stained blue, whereas the 
cytoplasm and extracellular matrix have varying degrees of pink staining.  
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Briefly, sections were stained with haematoxylin solution for 1 min at RT, and then the 
dye in excess was removed before washing slides in deionized water (2 rapid washes) and 
in tip water (1 wash/6 min). After drying the excess water, sections were stained with 
eosin solution for 5 sec at RT. The dye in excess was removed before washing slides in 
deionized water (1 min). Finally, air dried sections were mounted with resinous mounting 
medium before optical microscope analysis. 
Paraffin embedded samples were previously fixed in 10% buffered formalin for 24 h; 
thereafter, samples were rinsed in tip water to remove excess formalin and dehydrated by 
a series of alcohol baths of increasing strengths. In particular, dehydration occurred using 
an automatic processor Leica TP1020 (Leica, Wetzlar, Germany) performing a 
dehydration program of 10 h (total). Samples were soaked in alcohol baths (2 cycles in 
alcohol 70%; 2 cycles in alcohol 95%, 3 cycles in alcohol 100%), then in xylene (3 cycles) 
and paraffin (2 cycles). Finally, specimens were paraffin embedded using Leica EG 1150 
embedder and cut into 5 µm-thick serial sections. Sections were dewaxed by 2 cycles in 
xylene of 10 min each and then rehydrated by a series of alcohol baths of decreasing 
strengths (2 washes in 100% alcohol; 1 wash in 95% and 70% alcohol respectively) and 
1 wash in deionized water.  
 
6.2 Immunohistochemical analysis of explanted samples 
Immunological characterisation of the cells identified in contiguity with PVA was carried 
out with the following antibodies diluted in PBS: anti-CD3 (Polyclonal Rabbit Anti-
Human CD3, A 0452, DAKO, Milan, Italy) diluted 1:500; anti-F4/80 (sc-26643-R, Santa 
Cruz Biotechnology, CA, USA) diluted 1:800. Sections were incubated in 1% hydrogen 
peroxide in deionised H2O, to remove endogenous peroxidase activity and enhance 
antibody penetration into the tissue, and then washed in 0.01 M PBS. For both protocols, 
antigen unmasking was performed with 10 mM sodium citrate buffer, pH 6.0, at 90 °C 
for 10 min. Sections were then incubated for 30 min in blocking serum (0.04% bovine 
serum albumin (A2153, Sigma-Aldrich, Milan, IT) and 0.5% normal goat serum (X0907, 
Dako Corporation, Carpinteria, CA, USA) to eliminate unspecific binding, and then 
incubated for 1 hour at room temperature with the above primary antibodies. Primary 
antibody binding was revealed by incubation with anti-rabbit/mouse serum diluted 1:100 
in blocking serum for 30 min at room temperature (DAKO® EnVision + TM Peroxidase, 
Rabbit/Mouse, Dako Corporation, Glostrup, Denmark) and developed in 3,3’-
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diaminobenzidine for 3 min at RT. Lastly, sections were counterstained with 
haematoxylin. As negative control, sections were incubated without primary antibodies. 
 
7. Cell cultures  
Human articular chondrocytes were isolated from AC samples collected from two 
different patients categories: osteoarthritic and haemophilic donors. All patients 
underwent to total knee arthroplasty. 
 
7.1 Cartilage harvest and chondrocyte isolation 
Human AC samples were collected from donors who underwent total knee arthroplasty; 
only tissue from joints without signs of degenerative changes was used. The cartilage 
specimens were kept in basal medium DMEM and Nutrient Mixture F12, ratio 2:1, until 
further processed (within 24 h of sample collection). For chondrocyte isolation, cartilage 
was washed in PBS containing 2% of penicillin/streptomycin, minced finely and digested 
with 0.1% collagenase B in basal medium at 37 °C for 22 hours. The resulting cell 
suspension was collected and centrifuged at 1500 rpm for 5 min. Isolated cells were than 
seeded on 25 cm2-flasks (BD Falcon) at high density with complete medium as described 
below. 
 
7.2 Chondrocyte culture medium 
Chondrocytes were cultured at 37 °C in humidified atmosphere containing 5% CO2 with 
complete medium: DMEM/F12 (2:1) (Gibco) added with 10% fetal bovine serum (FBS) 
(Gibco), 0.4 µg/ml hydrocortisone, 8 ng/ml cholera toxin, 5 µg/ml insulin, 24 µg/ml 
adenine, 0.5 µg/ml transferrin, 136 pg/ml triiodothyronin, 1% Penicillin/Streptomycin 
solution (Sigma-Aldrich). The medium was changed at the sixth day and then every 3-4 
days.  
 
8. Chondrocyte characterization 
Before testing Haemophilic chondrocytes for their potential use in autologous cartilage 
restoration, a detailed characterization of cell population was performed to assess their 
distinctive properties according to literature. Chondrocytes isolated from AC samples of 
Non-Haemophilic patients were used as control. 
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8.1 Optical microscopy analysis.  
Cell cultures were daily observed by optical microscope DM/IL (Leica) and pictures were 
taken with a camera Nikon Digital Sight Ds-SMCc (Nikon Corporation).  
 
8.2 Reverse Transcriptase - Polymerase Chain Reaction  
Reverse Transcriptase - Polymerase Chain Reaction (RT-PCR) is a sensitive method for 
the detection of specific mRNA expression levels. Traditionally RT-PCR involves two 
steps: the RT reaction and PCR amplification. RNA is first reverse transcribed into cDNA 
using a reverse transcriptase and the resulting cDNA is used as templates for subsequent 
PCR amplification using primers specific for one or more genes.  
Briefly, the method provide: 
A) RT-Reaction 
a. Isolation of the template RNA. 
b. Priming for reverse transcription. To generate cDNA using the enzyme reverse 
trascriptase (RT), a primer is annealed to the template RNA. The primer can be 
gene specific primers, random primers or oligo-dT primers. 
c. First strand synthesis. The first strand of cDNA is synthetized using RT beginning 
at the primer annealing site. 
d. RT adds complementary nucleotide bases to the mRNA strand creating a strand 
of cDNA. 
e. Removal of RNA. The template strand of RNA is removed by treatment with 
RNAse H. The cDNA can now be used for amplification by PCR. 
B) PCR reaction 
f. The oligonucleotide primer is allowed to anneal to the template cDNA. 
g. Taq polymerase adds complementary nucleotides beginning at primer annealing 
site. 
h. The resultant product is a double stranded cDNA 
i. The three step process of denaturation, primer annealing and extrension are 
repeated to yield a detectable PCR product. The product can be visualized on an 
ethidium bromide stained agarose gel following electrophoresis. 
 
RT-PCR can also be carried out as one-step RT-PCR in which all reaction components 
are mixed in one tube prior to starting the reactions.  
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8.2.1 Expression of specific mRNA  
Extraction of total RNA 
mRNA was extracted using Trizol® Reagent (Sigma-Aldrich), a monophasic solution of 
phenol and guanidine isothiocyanate.  
Monolayer cultures of articular chondrocytes from Haemophilic and Non-Haemophilic 
patients were detached by treatment with trypsin-EDTA (Sigma-Aldrich), washed with 
PBS and finally centrifuged at 1500 rpm for 5 min. Cell pellets, obtained after the removal 
of washing buffer, were then treated first with 1 ml of Trizol for 5min. at RT and then 
with 200 μl of chloroform (Sigma-Aldrich). For a better separation of RNA, the samples 
were shaken gently for 15 sec. and afterwards incubated at RT for 3 min. Later, samples 
were centrifuged at 12000 rpm for 15min. at 4°C to obtain phase separation. Samples 
were resolved as a lower phase containing proteins, white interphase containing DNA and 
an upper aqueous phase containing RNA. Aqueous phase was collected carefully and 
RNA was precipitated by adding 500 μl of isopropanol (Sigma-Aldrich) (0.5 ml per 1 ml 
of Trizol used) and shaking by hand the sample. After 10 min. of incubation, samples 
were centrifuged at 1200 rpm for 10 min. at 4°C., the supernatant was removed and the 
resulting pellet was washed with 1 ml of cold 75% ethanol and then centrifuged at 8600 
rpm for 5 min. at 4°C. After the careful removal of the supernatant, the pellet was air 
dried for 10 min. and resuspended in 10 μl of RNase-free water (Sigma-Aldrich). RNA 
was quantitated by spectrophotometric analysis and then samples were stored at - 80 °C. 
Spectrophotometric quantitation of extracted RNA  
After extraction of total RNA, it was quantitated by spectrophotometric analysis. The 
absorbance of 1 μl of each sample was measured at the wavelength of 260 nm. using the 
spectrophotometer NanoDrop 2000 (Thermo Scientific, Waltham, MA, USA). At the 
same time, samples purity was also evaluated considering absorbance at 280 and 230 nm 
which is ascribable to absorbance wavelength of proteins and carbohydrates respectively. 
Gene expression studies were performed using RNA samples whose 260/280 ratio were 
in the range of 1.8 - 2.0. 
One Step RT-PCR 
Reverse transcription and specific amplification of RNA in cDNA were performed in a 
single tube using QIAGEN® OneStep RT-PCR Kit (Qiagen, Hilden, Germany). Its 
provides a blend enzymes: Sensiscript and Omniscript Reverse Transcriptases and 
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HotStarTaq DNA Polymerase, that allow both reverse transcription and PCR 
amplification to take place in the same reaction mix in a "one-step" reaction which is 
temperature-dependent. During reverse transcription, the HotStarTaq DNA Polymerase 
is inactive; while, during amplification, to the deactivation of the reverse transcriptase, 
corresponds DNA polymerase activation at a temperature of 95°C. The reaction mixture 
(25 μl) was prepared in ice using 1 μl of RNA at a concentration of 30 ng/μl, 3 μl forward 
primer (5 μM), 3 μl reverse primer (5μM), 1 μl dNTP mix (10mM), 1 μl Qiagen® One 
Step RT-PCR Enzyme Mix, 1 μl RNase inhibitor (125 U), 5μl 5X buffer and RNAse-free 
water. One Step RT-PCR was performed with the thermal cycler iCycler iQ™ (Bio-Rad). 
Specific oligo primers (Life technologies, Carlsbad, CA, USA) designed on Gene Bank 
sequences (Tab. 3) were used and the expression of HPRT was considered as internal 
control. 
Agarose gel Electrophoresis  
The electrophoretic analysis of PCR reaction products was performed by running samples 
on 2% agarose gel prepared in 1X TBE buffer (tris, 0.04mM Borate, 0.001M EDTA, pH 
8). For loading, 6 μl of amplified product were mixed with 2 μl of loading dye (Sigma-
Aldrich). As a reference marker to the molecular weights between 100 and 1000 bp, the 
PCR 100 bp Low Ladder was used. The bands of amplified samples were visualized by 
staining with Gel Red (0.1μl/ml) and exposure to UV light. Images were acquired with 
Gel Doc 2000 (Bio-Rad). 
 
 
Table 3. Primers for RT-PCR. 
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8.3 Flow cytometry evaluation 
To identify specific immunophenotype of articular chondrocytes from haemophilic 
patients in comparison with chondrocytes from Non-Haemophilic patients, flow 
cytometry analysis were performed.  
Flow cytometry is a technology that simultaneously measures and then analyses multiple 
physical characteristics of single particles, usually cells, as they flow in a fluid stream 
through a beam of light. The properties measured include a particle’s relative size, relative 
granularity or internal complexity, and relative fluorescence intensity. These 
characteristics are determined using an optical-to-electronic coupling system that records 
how the cell or particle scatters incident laser light and emits fluorescence. A flow 
cytometer is made up of three main systems: fluidics, optics, and electronics (Fig. 21). 
 The fluidics system transports particles in a stream to the laser beam for 
interrogation. 
 The optics system consists of lasers to illuminate the particles in the sample stream 
and optical filters to direct the resulting light signals to the appropriate detectors. 
 The electronics system converts the detected light signals into electronic signals 
that can be processed by the computer.  
 
 
Figure 21. The basic components of a flow cytometer. 
 
In the flow cytometer, particles are carried to the laser intercept in a fluid stream. Any 
suspended particle or cell from 0.2–150 µm in size is suitable for analysis. Cells from 
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solid tissue must be disaggregated before analysis. The portion of the fluid stream where 
particles are located is called the sample core. When particles pass through the laser 
intercept, they scatter laser light. Any fluorescent molecules present on the particle 
fluoresce. The scattered and fluorescent light is collected by appropriately positioned 
lenses. A combination of beam splitters and filters steers the scattered and fluorescent 
light to the appropriate detectors. The detectors produce electronic signals proportional 
to the optical signals striking them. List mode data are collected on each particle or event. 
The characteristics or parameters of each event are based on its light scattering and 
fluorescent properties (Fig. 22). The data are collected and stored in the computer. This 
data can be analysed to provide information about subpopulations within the sample. 
 
 
Figure 22. Cytofluorimetric analysis of cells. Characteristics of each event are based on its light scattering 
and fluorescent properties.  
 
Light scattering occurs when a particle deflects incident laser light. The extent to which 
this occurs depends on the physical properties of a particle, namely its size and internal 
complexity. Factors that affect light scattering are the cell's membrane, nucleus, and any 
granular material inside the cell. Cell shape and surface topography also contribute to the 
total light scatter. 
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Forward-scattered light (FSC) is proportional to cell-surface area or size. It is a 
measurement of mostly diffracted light and is detected just off the axis of the incident 
laser beam in the forward direction by a photodiode. FSC provides a suitable method of 
detecting particles greater than a given size independent of their fluorescence. 
Side-scattered light (SSC) is proportional to cell granularity or internal complexity. SSC 
is a measurement of mostly refracted and reflected light that occurs at any interface within 
the cell where there is a change in refractive index. SSC is collected at approximately 90 
degrees to the laser beam by a collection lens and then redirected by a beam splitter to the 
appropriate detector. 
Correlated measurements of FSC and SSC can allow for differentiation of cell types in a 
heterogeneous cell population (Fig. 23). 
 
 
Figure 23. Forward and side scatter data can be used to classify samples by size (FSC) and by internal 
complexity (SSC). 
 
By using fluorochrome-conjugated antibodies, flow cytometry allows the identification 
of specific cell markers. Fluorochrome are fluorescent compound absorbs light energy 
over a range of wavelengths that is characteristic for that compound. This absorption of 
light causes an electron in the fluorescent compound to be raised to a higher energy level. 
The excited electron quickly decays to its ground state, emitting the excess energy as a 
photon of light. This transition of energy is called fluorescence. The range over which a 
fluorescent compound can be excited is termed its absorption spectrum. As more energy 
is consumed in absorption transitions than is emitted in fluorescent transitions, emitted 
wavelengths will be longer than those absorbed. The range of emitted wavelengths for a 
particular compound is termed its emission spectrum (Fig. 24). 
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Figure 24. A typical fluorochrome absorption-emission spectral diagram is illustrated. Note the wavelength 
shift between excitation and emission. 
 
The argon ion laser is commonly used in flow cytometry because the 488-nm light that it 
emits excites more than one fluorochrome. Various fluorochromes can be used, among 
these the most common are: fluorescein isothiocyanate (FITC); phycoerythrin (PE); 
peridinin chlorophyll protein (PerCP); allophycocyanin (APC) (Fig. 25).  
 
 
Figura 25. Absorption (A) and emission (B) spectra of four common fluorochromes  
 
When a fluorescent dye is conjugated to a monoclonal antibody, it can be used to identify 
a particular cell type based on the individual antigenic surface markers of the cell. In a 
mixed population of cells, different fluorochromes can be used to distinguish separate 
subpopulations. The staining pattern of each subpopulation, combined with FSC and SSC 
data, can be used to identify which cells are present in a sample and to count their relative 
percentages. 
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8.3.1 Immunophenotype characterization 
Cells from Haemophilic and Non-Haemophilic patients (used as controls), at passage (P) 
2 were first harvested by treatment with trypsin-EDTA, centrifuged at 1500 rpm for 5 
min. and finally resuspended in PBS and 0.2% BSA. Hence, chondrocytes were stained 
with 2µl of phycoerythrin-conjugated antibodies, CD26, CD49c, CD44 and CD73; 
fluorescein isothiocyanate-conjugated antibodies, CD49e and CD151 and PerCP-
Cyanine5-conjugated antibody, CD49f. Labeling occured in 15 minutes at RT, in the 
dark. Isotypic antibodies served as controls. All the antibodies were purchased from 
BioLegend (San Diego, CA, USA), with the exception of CD151 and its isotype, 
purchased from Millipore (Billerica, MA, USA) (Tab. 4). At the end of the procedure, all 
samples were rinsed with PBS-BSA and centrifuged at 1500 rpm for 5 min. Analysis was 
performed on FACS Canto II (Becton Dickinson) resuspending samples in 200 μl of PBS-
BSA. For each sample, at least 10,000 events were analysed. Results were expressed as 
percentage of positive cells compared to the isotype negative control. 
 
 
Table 4. Antibodies used for flow cytometry. 
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9. Composite scaffold manufacture 
Three different scaffold groups were investigated to analyse their ability in sustaining 
chondrocytes adhesion and proliferation: the PVA hydrogel alone, the PVA hydrogel 
combined with W’s J derived matrix; the PVA hydrogel combined with AC derived 
matrix. 
Manufacture of scaffolds consists in a two-phase process: a) production of tissue-
matrices; b) construction of the PVA-matrix composite scaffold. 
 
9.1 Matrices manufacture 
9.1.1 Matrices from umbilical cord 
Ten fragments of umbilical cord of about 10 cm in length were obtained, with the 
mother’s consent, from full term caesarean deliveries and stored at - 80 °C until use. 
All samples were thawed at room temperature (RT) and rinsed four times in PBS 
containing 2% penicillin/streptomycin solution to remove contaminating red blood cells. 
After washing, the umbilical vessels were manually removed and the jelly was minced 
into small fragments that were all gathered in a 50 ml tube (BD-Falcon). Fragments were 
then decellularized according to the detergent-enzymatic method by Meezan. (Meezan et 
al., 1975). Briefly, samples were soaked in: distilled water for 72 h at 4 °C, changing the 
aqueous solution every 2 h; 4% sodium deoxycholate for 4 h at RT; 2000 KU (Kunitz 
Units) DNase-I in 1 M NaCl for 2 h at RT.  
The presence of cellular elements was verified through immunohistochemical staining: 
after each detergent-enzymatic cycle, 10 slides from each sample were mounted with 
Vectashield mounting medium for fluorescence with DAPI (Vector Laboratories, 
Burlingame, CA, USA) and analysed with a fluorescence microscope (Leica). As control, 
native jelly samples were stained. 
Only after having ascertained the complete tissue decellularization, 1 g of tissue was put 
in a 50 ml tube (BD Falcon), soaked with 15 ml of 10% acetic acid solution (2.5 M) 
(Sigma-Aldrich) in deionized water (dH2O) and homogenized at 0 °C in a Ultra-Turrax 
homogenizer (Janke & Kunkel GmbH, Staufen, Germany, EU) 8 times/20 sec with 
intervals of 5 min. This stage was lead in ice bath. Thereafter, 400 ul of matrix solution 
were cast into each well of a 24-well cell culture plate (mould) and frozen at -20 °C before 
being lyophilized overnight using an under-vacuum evaporator (Speed Vac Concentrator 
Savant, Instruments Inc., Farmingdale, NJ, USA). 
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9.1.2 Matrices from articular cartilage tissue  
Human articular cartilage tissue was obtained according to local Ethics Committee 
guidelines from 5 male donors who underwent total joint replacement surgery. Samples 
were stored at – 80 °C until use.  
All samples were thawed at RT and rinsed four times in PBS containing 2% 
penicillin/streptomycin solution. After washing, tissue samples were minced into small 
fragments and treated as described previously for umbilical cord-derived ones. At the end 
of each cycle, the presence of cellular elements was verified through 
immunohistochemical staining with Vectashield mounting medium for fluorescence with 
DAPI; as control, native articular cartilage samples were used. 
 
10. Quality assessment of ECM after decellularization treatment 
10.1 Histologic evaluation 
Once the absence of cellular elements was ascertained, specimens of each tissue 
underwent histological analysis.  
Wharton’s jelly and articular cartilage fragments, after being soaked in isopenthane, were 
frozen in liquid nitrogen fumes and then were kept at – 80 °C for 24 h before being ice-
included and sliced in 7 µm serial slices using a cryomicrotome (Leica CM 1850 UV). 
These sections were fixed with acetone and stained with Masson trichromic and Movat 
pentachromic staining. Masson Trichrome Goldner with Light Green Kit (Bio-Optica) 
and Movat Pentachromic Staining Kit (Diapath, Bergamo, Italy, EU) were used 
respectively. As control, native articular cartilage and Wharthon’s jelly samples were 
adopted. 
Masson Trichrome Goldner is a recommended method for connective tissue. Four 
different stains are used: Weigert’s iron hematoxylin for nuclei, picric acid for 
erythrocytes, a mixture of acid dyes (acid fuchsin-”ponceau de xylidine”) for cytoplasm 
and light green for collagen.  
Briefly, sections were bring to distilled water and upon each one were put 6 drops of 
Weigert’s iron hematoxylin A solution (reagent A) and 6 drops of Weigert’s iron 
hematoxylin B solution (reagent B) which were left to act for 10 min. Without washing, 
the slides were drained and on the sections were put 10 drops of Picric acid alcoholoic 
stable solution (reagent C) for 4 min. After a quick wash in distilled water, 10 drops of 
Ponceau acid fuchsin according to Masson (reagent D) were put for 4 min, followed by a 
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wash in distilled water. Then, 10 drops of phosphomolibdic acid solution (reagent E) were 
left for 10 min. Without washing, slides were drained and 10 drops of light green solution 
according to Goldner (solution F) were put on and left for 5 min. Finally, sections were 
washed in distilled water and mounted with resinous mounting medium (Bio-Mount HM). 
This method was useful to demonstrate nuclei and gametes (black); cytoplasm (red); 
collagen, mucus (green).  
Movat pentachromatic stain is used to highlight collagen, muscular tissue, reticular fibres, 
mucines and fibrin. Eight different stains are used: alcian blue solution (reagent A), 
alkaline alcoholic solution (reagent B), hematoxylin alcoholic (reagent C1), solution 
iodure-iodide (reagent C2), ferric chloride (reagent D), sodium thiosulphate (reagent E), 
Briebrich scarlet – fuchsine acid (reagent F), phosphotungstic acid (reagent G), alcoholic 
safran (reagent H). 
Briefly, sections were bring to distilled water and upon each one was put reagent A for 
20 min. After washing with running water (5 min), reagent B was left for 60 min and then 
washed for 10 min. Reagent C was obtained mixing C1 and C2 and sections were stained 
with it for 15 min before washing with distilled water. Then, reagent D was put till elastic 
fibres become black and soon after it was washed at first with distilled water and 
subsequently with a 0.5% solution of acetic acid in distilled water. Afterwards, sections 
were stained with reagent E for 1 min which was than washed in running water (10 min) 
and then distilled water. Briebrich scarlet – fuchsine acid (reagent F) was put for 3 min, 
and washed with a 0.5% solution of acetic acid in distilled water. Soon after reagent G 
was put upon sections for 10 min, washed in a 0.5% solution of acetic acid in distilled 
water and then sections were dipped in absolute ethyl alcohol before adding reagent H 
for 15 min. Finally sections were dehydrated in absolute ethyl alcohol for 2 min and 
mounted with resinous mounting medium.  
According to this method, nucleus and elastic fibres are black stained, collagen and 
reticular fibres appear yellow, mucines are blue, fibrinoid, fibrins are intense red 
coloured.  
Mounted slides were observed using fluorescence microscope. 
 
10.2 Protein quantitation assay of decellularized ECMs 
Total ECM proteins were quantitated by bicinchoninic acid (BCA) method using the 
Pierce™ BCA Protein assay kit (Thermoscientific, Rockford, IL, USA). 
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The principle of this method is that protein can reduce Cu+2 to Cu+1 in an alkaline solution 
(the biuret reaction) and result in a purple colour formation by bicinchoninic acid which 
is formed by the chelation of two molecules of BCA with one cuprous ion (Fig. 26). The 
macromolecular structure of protein, the number of peptide bonds and the presence of 
four particular amino acids (cysteine, cystine, tryptophan and tyrosine) are reported to be 
responsible for colour formation with BCA. This water-soluble complex exhibits a strong 
absorbance at 562nm that is nearly linear with increasing protein concentrations over a 
broad working range (20-2000μg/mL). The BCA method is not a true end-point method; 
that is, the final colour continues to develop.  
 
 
Figure 26. The reaction of BCA with cuprous ion. Two molecules of BCA bind to each molecule of copper 
that had been reduced by a peptide-mediated biuret reaction  
 
Accordingly, protein concentrations generally are determined and reported with reference 
to standards of a common protein such as BSA. A series of dilutions of known 
concentration are prepared from the protein and assayed alongside the unknown(s) before 
the concentration of each unknown is determined based on the standard curve. 
The analysis was performed on five different donor samples of W’s J and AC matrix 
homogenates, obtained as described previously. Acetic acid homogenates (1 ml) were 
centrifuged at 12,000 rpm for 5 min at 4 °C and protein pellets were dissolved in 1 ml of 
1% sodium dodecyl sulphate (SDS). For the assay quantification, 8 dilutions of the stock 
standard BSA (2 mg/ml) and a blank solution were prepared. Subsequently, 25 μl of each 
dilution solution and the samples to be quantified were placed in 96-well plates and 200 
μl of Working Reagent was added to each well. The Working Reagent solution was 
previously prepared by mixing 50 parts of Reagent A (sodium carbonate, sodium 
Bicarbonate reagent for the detention of BSA and sodium tartrate in 0.2 N NaOH), with 
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a part of reagent B (solution of copper sulphate to 4%). The plate was then incubated for 
30 min at 37°C. The colorimetric reactions were analyzed at 562 nm using a Microplate 
autoreader EL 13 (BIO-TEK instruments Inc., Winooski, Vermont USA). The total 
protein amount was determined using a standard curve for BSA.  
 
11. Preparation of PVA hydrogel composite scaffolds  
An aqueous solution of 16 wt % PVA (Mw 146,000-186,000 Da, 99+% hydrolysed) was 
prepared by dissolving a pre-weighted quantity of PVA in deionized water and heating it 
for 48 hours at 90 °C, under stirring, until complete dissolution. The PVA solution was 
then slowly cooled down to RT. A quantity of 0.3 g of the PVA solution was cast into 
each well of a 24-well cell culture plate (mould) (BD Falcon, USA) and a thin matrix-
layer, prepared as described in Paragraph 9.1, was then set down carefully upon each 
PVA solution just poured. A freeze-thaw treatment was used to physically cross-link the 
hydrogel and to embed the lyophilized matrix upon the hydrogel. Briefly, the coated plate 
was frozen at – 20 °C and slowly thawed at – 2.5 °C for 5 times. At the end of the freeze-
thawing treatment, composite scaffolds were kept at – 20 °C until use. As control, freeze-
thawed PVA hydrogels without any coating were used.  
 
11.1 Composite scaffold morphological characterization  
Ox 1% PVA and Ox 1% PVA composite scaffolds morphology was investigated by SEM. 
Samples were fixed with 2.5 % glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2) for 
24 h and then dehydrated. Dehydration was performed by soaking each sample in 
increasing concentrate alcohols (30-95%) (1h/alcohol). After Critical Point Drying and 
gold sputtering, samples were observed by a scanning electron microscope (Stereoscan-
205 S; Cambridge instruments, Pine Brook, NJ, USA) of CUGAS, Interdepartmental 
Service Centre at University of Padua. 
 
12. Chondrocytes culture on scaffolds 
Primary human chondrocytes from P2, isolated and cultured as previously described 
(Paragraphs 7.1 and 7.2) , were used for seeding on scaffolds. PVA/W’s J and PVA/AC 
scaffolds were washed 4 times of 2 h each, in PBS solution containing 2% 
penicillin/streptomycin. The purpose was to disinfect supports and to remove any residual 
of acetic acid solution used to prepare matrices. Then they were incubated at 37 °C in 
basal medium over-night.  
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At the time of cell seeding, monolayer cultures of AC from Haemophilic and Non-
Haemophilic patients were detached by treatment with trypsin-EDTA. Chondrocytes 
suspensions, after deactivation of trypsin with basal medium DMEM/F12 (2:1) added 
with 10% FBS, were centrifuged at 1500 rpm for 5 min. Hence, cell pellets were 
resuspended in complete medium. The resulting cell suspensions were divided into 4 
tubes, as the cell seeding was carried out in 4 times interspersed with a break of 15 min 
each during which supports were manteined at 37 °C in cell culture incubator. At each 
time, scaffolds (previously placed in each well of a 24-multiwell) were seeded with 100 
µl of cell suspension. After seeding, each sample was added in complete medium, to a 
final volume of 1000 µl. 
Scaffolds were seeded with chondrocytes (20,000 cells/cm2) and incubated at 37˚C in a 
5% CO2 humidified atmosphere. 
 
13. Evaluation of cell adhesion and proliferation on composite scaffolds  
13.1 Scanning Electron Microscopy 
After 7 and 14 days of Haemophilic and Non-Haemophilic articular chondrocytes growth 
on Ox 1% PVA; W’s J/Ox 1% PVA; AC/Ox 1% PVA scaffolds, cell adhesion was 
evaluated by SEM. 
Culture medium was removed and scaffolds on wells were washed gently with PBS. After 
taking out the buffer, samples were fixed with 2.5 % glutaraldehyde in 0.1 M cacodylate 
buffer (pH 7.2) for 24 h and then dehydrated. Dehydration was performed by immersion 
in increasing concentrated alcohols (30-95%) (1h min/alcool) (1h/alcohol). After Critical 
Point Drying and gold sputtering, samples were observed by a scanning electron 
microscope (Stereoscan-205 S; Cambridge instruments, Pine Brook, NJ, USA) of 
CUGAS, Interdepartmental Service Centre at University of Padua. 
 
13.2 Thiazolyl Blue Tetrazolium Blue assay 
Proliferative activity of cells seeded on composite scaffolds and, in parallel, matrices 
potential in sustaining chondrocytes proliferation, was measured by Thiazolyl Blue 
Tetrazolium Blue (MTT).  
After 7 and 14 days from seeding, Haemophilic and Non-Haemophilic articular 
chondrocytes proliferative activity on Ox 1% PVA; W’s J/Ox 1% PVA; AC/Ox 1% PVA 
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scaffolds, was measured. Cells grown on wells of a 24-multiwell plate were used as 
control. 
Once culture medium was removed, scaffolds and cells on wells were washed gently with 
PBS. After taking out the buffer, hydrogels were moved to clean 24 well plates using a 
tweeze and then samples were treated with 500 µl of MTT (0.5 mg/ml) in basal medium 
for 4 h at 37 °C in humidified atmosphere containing 5% CO2. Afterwards, MTT solution 
was removed and formazan precipitates were dissolved in 300 µl of 2-propanol acid (0.04 
M HCl in 2-propanol). Dissolution occurred placing the 24 well plates on a tilting shaker 
(Asal, Milano, Italy) for 20 min at RT. Dissolved formazan precipitates were collected 
carefully and moved to a 96 well plates. Optical density was measured at 570 nm, using 
a Microplate autoreader EL 13 (BIO-TEK instruments Inc., Winooski, Vermont USA). 
Results were expressed as number of cells grown on seeded surface. 
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RESULTS 
 
 
1. Oxidized polymers characterization 
1.1 Carbonyl content quantification 
Oxidized PVA carbonyl content was determined by DNPH assay. 2,4-dinitrophenyl 
hydrazine is tipically used to determine carbonyl groups of aldehydes and ketones; 
reacting with carbonyls, it leads to the formation of hydrazone derivatives. Fig. 27 
represents GPC chromatograms of PVA carbonyls derivatisation with DNPH: as shown, 
with the increasing of oxidation degree, a higher hydrazone amount was detected. 
Average carbonyl content was equal to 5 µmol/mg and 11.4 µmol/mg in 1% Ox and 2% 
Ox PVA, respectively. PVA was considered as negative control. 
 
 
Figure 27. GPC chromatograms of PVA, 1% Ox and 2% Ox PVA after DNPH treatment. Peaks represent 
size exclusion configurations of high molecular weight phenylhydrazone derivatives eluted from a PD-10 
column and monitored at 375 nm. Free DNPH profile is not shown. Mobile phase: PBS/Methanol 70/30 
(v/v); flow rate: 1 ml/min. Data are representative of three independent experiments. 
 
1.2 Lysozyme covalent binding 
Sodium cyanoborohydride is a reducing agent that was used to establish a stable covalent 
interaction between carbonyls groups of oxidized PVA and amino groups of lysozyme, 
through reduction of intermediate Schiff’s bases, otherwise not visible. By GPC, we 
obtained chromatograms of 1% Ox (Fig. 28 A) and 2% Ox (Fig. 28 B) PVA incubated 
with lysozyme at different end-points (4, 24, 50, 120 h). Since 4 h of incubation, the 
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typical band absorbing at 280 nm is recognizable. After 24 h, the lysozyme bounded to 
polymers reached about 22% (1% Ox PVA) and 45% (2% Ox PVA) of the initial total 
amount. Bounded lyzozyme increased progressively up to 120 h. 
 
 
Figure 28. GPC evaluation of covalent interaction between lysozyme and 1% Ox (A) and 2% Ox (B) PVA. 
Chromatograms show size exclusion configurations of bound and free lysozyme eluted from Superose 6 
10/300 GL and monitored at 280 nm. Mobile phase: PBS; flow rate: 0.5 ml/min. Data are representative of 
three independent experiments. 
 
2. Scaffold characterization 
2.1 Morphological analysis by Scanning Electron Microscopy 
SEM micrographs were obtained to characterize the superficial morphology of the 
scaffolds, investigating contingent differences ascribable to oxidation. According to this 
analysis, PVA scaffolds showed a smooth and regular surface (Fig. 29 A). Conversely, 
1% and 2% oxidized PVA supports had a different morphology, characterized by a rough 
surface (Fig. 29 B,C). 
 
 
Figure 29. SEM investigation of PVA (A), 1% Ox PVA (B) and 2% Ox PVA (C) scaffold surface 
morphology. Micrographs show that structural remodeling occurs with increasing oxidation degree. 
Magnification x8000. 
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2.2 Mechanical characterization.  
The instrument expressed data stress-strain curves in N versus mm. However, it is more 
useful to convert applied force in MPa, dividing the force applied by the area of the 
resistant section of each sample, and expressing the deformation in %. The result is a 
stress-strain graph in which the slope of the curve in the elastic range directly indicates 
the elastic modulus of the material (Young's modulus). The slope of the curve is 
calculated by linear interpolation.  
The stress vs. strain curves of PVA (Fig. 30 A,D) Ox 1% PVA (Fig. 30 B,E) and Ox 2% 
PVA (Fig. 30 C,F) were superimposable and no hysteresis was observed, suggesting high 
resilience for all samples. Moreover, increasing the oxidation degree, polymer elastic 
modulus decreased, showing a reduction in stiffness (Tab. 5). No significant difference 
(p < 0.05) was detected in the values of the elastic modulus between dried and swelled 
samples.  
Conversely, considering cartilage tissue, the stress vs. strain curves were no longer 
superimposable showing a clear hysteresis (e.g., energy loos): some of the work done 
during the loading phase was dissipated and could be not recovered upon uploading (Fig. 
31). As shown in Tab. 5 higher values of the Young’s modulus are ascribable to cartilage 
tissue, in comparison to hydrogels. 
 
 
 
Figure 30. Stress-strain curves of neat PVA samples (A, D), ox 1% (B, E) and ox 2% (C, F) analyzed dried 
(A, B, C) or after immersion in solution saline (D, E, F). 
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Figure 31. Stress-strain curves of cartilage samples 
 
 
Table 5. Values of the elastic modulus (MPa) of PVA, Ox 1% and Ox 2% PVA samples 
 
2.3 Dynamic Light Scattering.  
The dimension and the homogeneity of PVA, 1% Ox and 2% Ox PVA molecules were 
investigated in water solutions by DLS analysis. Size distribution of the polymer samples 
was reported as percent volume (Fig. 32). Mean hydrodynamic size values were of about 
28 nm for PVA, 23 nm for 1% Ox PVA and 16 nm for 2% Ox PVA. The shift between 
the maximum of the three curves represents the decrease of particles mean size; the areas 
below the curves represent the extent of dimensional dispersion. Along with oxidation, 
the hydrodynamic radius of particles decreased. It is also noteworthy that 2% Ox PVA 
showed a broader size distribution peak in comparison with PVA and 1% Ox PVA, 
suggesting its higher degree of polydispersity. 
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Figure 32. DLS analysis of PVA and oxidized PVA molecules: size distribution in percent volume. Along 
with oxidation degree, hydrodynamic radius of particles decreased. Note the broader distribution peak of 
2% Ox PVA, ascribable to higher polydispersity. Data are representative of three independent experiments. 
 
2.4 Differential Scanning Calorimetry. 
 The DSC analysis allowed to measure melting temperatures, enthalpies, and crystallinity 
degree of PVA gels. Thermograms are shown in Fig. 33, while results are summarized in 
Tab. 6. Samples were characterized by an endothermic broad band in the range between 
80 and 160 °C, which can be ascribed to the evaporation of residual water. Following, a 
sharp peak can be observed, related to the melting of PVA, whose intensity decreases as 
oxidation rate increases. Oxidation seems to affect the PVA melting temperature and 
crystallinity degree, which show to lower as carbonyl content arises (Tab. 6).  
 
Figure 33. DSC thermograms of PVA and oxidized PVA samples. 
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Table 6. Thermal properties of PVA gels. Hydrogel Tm and ΔHm slightly decrease along with oxidation 
degree, indicating a gradual loss of crystallinity, as shown by Xc calculated values. 
 
2.5 Swelling test.  
Both 1% and 2% Ox PVA hydrogels showed rapid swelling ratio of 60% and 110% 
respectively in 24 h. Swelling then decelerated until an equilibrium was reached at 
approximately 70% (1% Ox PVA) and 40% (2% Ox PVA) mass increase after 288 h, 
remaining steady for the duration of the experiment. Conversely, PVA hydrogels 
displayed different swelling ratio, increasing in mass by about 20% within 24 h. Swelling 
continued, albeit at a slower rate until equilibrium was reached after approximately 288 
hours (Fig. 34). 
 
 
Figure 34. Swelling ratio as a function of time for cross-linked PVA, 1% and 2% Ox PVA hydrogels in 
PBS at 37 °C. By 24 h, all samples showed the maximum swelling ratio. Equilibrium was reached after 288 
h in solution.  
 
3. Protein release potential of PVA and oxidized PVA hydrogels.  
BSA and TGF-β1 release, at different end-points, was investigated to assess the potential 
of scaffolds for controlled drug delivery. Results are shown in Fig. 35 (BSA) and Fig. 36 
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(TGF-β1): both oxidized hydrogels sustain protein delivery better than PVA; furthermore, 
a higher protein release was monitored for 2% Ox than 1% Ox PVA scaffolds.  
Considering BSA (Fig. 35), an initial exponential release was clear (within 24 h); 
afterwards, according to UV spectra, protein release was sustained up to 144 h. 
 
 
Figure 35. BSA release profiles of PVA and oxidized PVA scaffolds. Protein release is higher for 2% Ox 
PVA and 1% Ox PVA compared to PVA itself. Data are representative of three independent experiments. 
 
TGF-β1 release was evaluated measuring fluorescence intensity of loaded scaffolds 
washing solutions; the fractions after 72 hour-incubation were pooled and their 
fluorescence measured. In Fig. 36, emission spectra of the solutions after incubation with 
the three hydrogels are reported: the peak at nearly 300 nm is due to tyrosine, while the 
broad band on the right is ascribable to tryptophan. Fluorometric analysis highlighted that 
released TGF-β1 increased along with scaffold oxidation rate.  
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Figure 36. TGF-β1 release profiles of PVA and oxidized PVA scaffolds. Spectra are of washing solutions 
after 72 hours incubation. 
 
As TGF-β1 shows a promising potential in promoting chondrocyte proliferation (Leipzig 
et al., 2006), a MTT assay was performed on ACs co-cultured with loaded scaffolds. A 
significant increase of proliferative activity assessed effective loading and release. 
Seventy-two hours from seeding, cells co-cultured with 1% Ox and 2% Ox PVA showed 
a higher proliferation rate (p<0.01) compared to chondrocytes/PVA co-cultures. The 
same trend was recorded also at 7 d from seeding (Fig. 37). These results, beyond 
highlighting the effectiveness of oxidized PVA in loading and releasing proteins, allowed 
us to rule out any modified PVA cytotoxicity. 
 
 
Figure 37. Chondrocyte proliferation after 72 h and 7 d of co-culture with TGF-β1 loaded PVA, 1% Ox 
and 2% Ox PVA scaffolds (**: p<0.01 with respect to Ctrl; ▲▲: p<0.01 with respect to PVA). 
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4. In vivo scaffold degradation.  
No implanted mice were euthanized or died prematurely due to scaffold related 
complications. Careful surveillance of the mice in the weeks after surgery did not show 
systemic signs of infection, neither local signs of rejection or inflammation. At the end of 
the 12-week period of in vivo implantation, preliminary evidences were gathered (Fig. 
38). Size and integrity of explanted oxidized scaffolds were visually compromised (Fig. 
38 F,I) compared to pre-implant supports (Fig. 38 D,G). In particular, degradation rate 
increased along with PVA oxidation degree. Conversely, PVA scaffolds did not show 
remarkable biodegradation: gross appearance after explant was similar to pre-implant one 
(Fig. 38 A,C). 
 
 
Figure 38. Gross appearance of pre-implant (A, D, G) and explanted (C, F, I) PVA, 1% Ox and 2% Ox 
PVA scaffolds. In (B), (E), (H) implants are shown before removal (12-weeks after surgery). 
 
SEM analysis of explants highlighted surface differences between PVA, 1% Ox and 2% 
Ox PVA scaffolds (Fig. 39 A,B). In particular, both PVA and 1% Ox PVA explants 
showed an identifiable polymeric structure, even though their surface appeared 
deteriorated in comparison to pre-implant controls. Conversely, 2% Ox PVA surface was 
no longer recognizable: SEM micrographs reveal the presence of disorganized collagen 
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fibers (Fig. 39 C) which should be attributed to scaffold reabsorption and substitution by 
new connective components.  
 
Figure 39. SEM investigation of PVA (a), 1% Ox PVA (b) and 2% Ox PVA (c) surface morphology at 12-
weeks. Compared to pre-implantation controls (A,B,C). PVA (a) and 1% Ox PVA (b) explanted scaffolds 
show typical polymeric surface features. Otherwise, 2% Ox PVA explants (c) were substituted by collagen 
fibers. Magnification x8000.  
 
4.1 Histological and immunohistochemical analysis.  
OCT-embedded samples proved more useful for evaluation of PVA characteristics, as 
PVA underwent volume changes and modifications of its characteristics along the various 
processing phases of formalin-fixed samples. Also in frozen samples, PVA sections were 
very difficult to be obtained without ruptures, dislocations or folds. However, apart from 
these artefactual modifications, PVA texture was intact, without areas of degradation and 
reabsorption. Conversely, 1% Ox PVA showed partial degradation and 2% Ox PVA was 
nearly not visible, in spite of exhaustive serial sectioning of samples, due to almost 
complete degradation. On biomaterials, no cellular adhesion occurred. Furthermore, 
while PVA-hydrogel surfaces remained smooth and transparent, oxidized PVA sections 
were amorphous and opaque (Fig. 40). 
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Figure 40. Hematoxylin and Eosin staining of PVA scaffolds explanted after 12 weeks of in vivo subcutis 
implantation. Note the absence of degradation and cell infiltration of PVA scaffold, ruptures and folding 
being ascribable to post-sampling artefactual changes (A, D). Conversely, 1% (B, E) and 2% (C, F) Ox 
PVA appeared much more compromised after exposure to biological fluids, being the second one almost 
no more visible next to the implant site. Magnification: (A, B) x12.5; (C) x25; (D, E, F) x100. 
 
Paraffin-embedded samples were mainly used for specific analysis of the tissues 
surrounding the implanted materials (Fig. 41). In all the samples, both from PVA and 
oxidized PVAs, severe inflammatory reactions were not present, but only slight 
infiltration of the connective tissue immediately superficial to the implanted material. 
Implant of 2% Ox PVA caused a slightly higher infiltration of the surrounding connective 
tissues. As it regards immunological characterization, most infiltrating cells were positive 
for CD3 or F4/80, consistently with lymphomonocytic nature of the infiltration. Sections 
incubated without primary antibodies showed no immunoreactivity, confirming the 
specificity of the immunostaining. 
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Figure 41. Histological and immunohistochemical analysis of PVA scaffolds explanted after three months 
of in vivo subcutis implantation. Note more numerous lymphomonocytic cells after implant of 2% oxidized 
PVA. Magnification: (A, D, G) x100; (B, C, E, F, H, I) x200. 
 
5. Evaluation of acellular ECMs 
5.1 Immunofluorescence and histological analysis 
Umbilical cord W’s J and AC were completely decellularized with 3 and 7 detergent-
enzymatic cycles respectively; DAPI staining was used to assure decellularization degree 
after each cycle. Cartilage tissue resulted more resistant to cell removal compared to W’s 
J; already one cycle induced an appreciable disappearance of cellular elements in the 
umbilical cord derived matrix. The histological sections of native and decellularized 
ECMs stained with DAPI are presented in Fig. 42 A,G and Fig. 42 B,H, respectively.  
ECMs morphology before and after the decellularization treatment was evaluated by 
means of Masson trichromic staining, which demonstrated a similar protein content of 
W’s J and AC samples. In particular, both matrices mainly consist of collagen fibers and 
mucus, as shown by the green staining of native (Fig. 42 C,I) and decellularized (Fig. 42 
D,L) tissues. 
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Movat pentachromic staining allowed us to detect red fibrin and yellow collagen 
components in native W’s J (Fig. 42 E). Moreover, in native AC (Fig. 42 M) and acellular 
ECMs (Fig. 42 F,N), blue and yellow colors indicate the presence of mucins and collagen 
fibers respectively. 
 
 
Figure 42. Histological evaluation of decellularized ECMs (B, D, F, H, L, N) versus native tissues (A, C, 
E, G, I, M). Magnification: x100. 
 
5.2 Protein quantitation of decellularized ECMs  
After ECM decellularization treatment, BCA assay was performed to control contingent 
sample-to-sample variations in total protein amount. Matrix homogenates of W’s J and 
AC, gained from different donors, were compared. Total protein content for W’s J and 
AC ECMs resulted of 29.2 and 24.8 mg per gram of tissue, respectively (mean values). 
No statistically significant difference was found between samples of each study group 
(Fig. 43). 
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Figure 43. Total protein quantitation by BCA assay in decellularized Wharton’s jelly and articular cartilage. 
 
6. Characterization of composite scaffolds 
SEM micrographs were obtained to characterize the superficial morphology of scaffolds 
before chondrocyte seeding (Fig. 44). One percent oxidized PVA scaffolds showed a 
smooth surface (Fig. 44 A). Conversely, 1% Ox PVA/W’s J and 1% Ox PVA/AC 
scaffolds have a different surface morphology: the first is quite regular, smooth and with 
convolution-like structures (Fig. 44 B); the second has a more irregular spongy 
appearance (Fig. 44 C). 
 
 
Figure 44. SEM investigation of 1% Ox PVA (A), 1% Ox PVA/W’s J (B) and 1% Ox PVA/AC (C) scaffold 
surface morphology. The edge of 1% Ox PVA scaffold not covered by W’s J and AC matrix is represent 
in (b) and (c), respectively. Magnification: x200 (A, B, C); x50 (b, c). 
 
7. Characterization of chondrocyte monolayer cultures 
7.1 Morphological analysis 
Freshly isolated chondrocytes from AC of Non-Haemophilic (A) and Haemophilic (B) 
patients were small and round and they initially grown as a suspension culture. Six days 
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after AC enzymatic digestion, adherent cells were observed. At a subconfluence state, 
both chondrocytes polpulations showed the classic round or polygonal shape with small 
membrane extroflessions (Fig. 45 a,b). Chondrocytes were expanded in culture up to 
passage 4, hereafter their proliferation rate started to decrease and their morphology 
changed to elongated fibroblast-like phenotype.  
 
Figure 45. Gross appearance of human AC from Non Haemophilic (A) and Haemophilic (B) patients. 
Analysis by optical microscopy of human AC chondrocytes from Non-Haemophilic (a) and Haemophilic 
(b) patients. Images are referred to cells at a subconfluent state P2. Magnification: x100. 
 
7.2 Expression of specific mRNA 
Before seeding on 3D scaffolds, isolated human chondrocytes from Non-Haemophilic 
and Haemophilic patients were characterized for the expression of specific cartilage 
markers. Gene expression analysis by RT-PCR showed that both AC-derived cell 
populations are active in the transcription of typical chondrocyte mRNAs: collagen type 
II, and IX, cartilage oligomeric matrix protein, aggrecan, SOX9 (Fig. 46 A,B). The 
housekeeping gene HPRT1 was used as a control. 
Results 
88 
 
 
Figure 46. Gene expression profile of isolated N-Haemophilic chondrocytes (A) versus Haemophilic 
chondrocytes (B) identified by RT-PCR. Housekeeping gene HPRT1 was tested for all samples. 
 
7.3 Immunophenotype 
To define the immunophenotype of AC chondrocytes of Haemophilic and Non-
Haemophilic patients, cell surface molecules expressed on cells were evaluated by flow 
cytometry. Chondrocytes of were cultured for 2 weeks in monolayer and P2 was 
investigated. The analysed cell surface molecules were classified into different categories 
according to their function: adhesion molecules (CD44; CD49c; CD49e; CD49f), 
receptors (CD151), and other surface molecules as ecto-enzyme molecules (CD26; 
CD73). Flow-cytometry showed that both subcultures consisted of 
CD44+/CD49c+/CD49e+/CD151+/CD73+/CD49f-/CD26- cells (Fig. 47). 
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11.7  
Figure 47. Immunophenotype evaluation by flow cytometry of AC chondrocytes from Non-Haemophilic 
(A) and Haemophilic patients (B). Data are expressed as percentage of positive cells (blue and red profile 
respectively) compared to isotypic control (black profile). 
 
8. Chondrocytes growth on 3D scaffolds 
Haemophilic and Non-Haemophilic chondrocyte’s distribution and proliferative activity 
on scaffolds was evaluated by SEM and MTT assay.  
 
8.1 Scanning Electron Microscopy analysis 
According to SEM micrographs, at day 7 and 14 from seeding no cell adhesion and 
proliferation was visible on 1% Ox PVA scaffolds. On the contrary, Non-Haemophilic 
and Haemophilic chondrocytes were visible both on 1% Ox PVA/W’s J and on 1% Ox 
PVA/AC scaffolds at the same end-points.  
In particular, at day 7 from seeding, both chondrocytes populations appeared well 
distributed on 1% Ox PVA/AC (Fig. 48 B,D) and 1% Ox PVA/W’s J (Fig. 48 A,C) 
scaffolds. At day 14, both chondrocytes populations extensively colonised scaffold 
surfaces, forming a homogeneous monolayer (Fig. 48 F,H;E,G). 
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Figure 48. Evaluation by SEM of Non (N)-Haemophilic (A, B; E, F) and Haemophilic chondrocytes (C, 
D; G, H) growth on 1% Ox PVA/ W’s J scaffolds (A,C; E,G) and 1% Ox PVA/AC scaffolds (B,D; F,H). 
Cell cultures were at analysed 7 d (A-D) and 14 d (E-H) from seeding. Magnification: x500. 
 
8.2 Thiazolyl Blue Tetrazolium Blue assay 
According to MTT assay, 1% Ox PVA did not sustain cell adhesion and proliferation (not 
shown). Seven days from seeding, colonization of 1% Ox PVA/W’s J and 1% Ox 
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PVA/AC scaffolds occurred, even though such differences were observed. Considering 
matrices attitude in sustaining chondrocytes proliferation, exists a difference between 
W’s J and AC. In fact, Non-Haemophilic chondrocytes proliferate higher on AC matrix 
than on W’s J matrix (p≤0.05). Moreover, considering cell populations, Non-Haemophilic 
chondrocytes have a substantial growth in comparison with Haemophilic chondrocytes 
on AC matrix (p≤0.05). At day 14 from seeding any difference in proliferation rate was 
identified neither between matrices, nor between cells. Non-Haemophilic and 
Haemophilic chondrocytes growth on tissue culture-treated polystyrene plates of was 
considered as internal proliferation control (Ctrl) (Fig. 49). 
  
 
Figure 49. Cell proliferation following seeding on 1% Ox PVA/W’s J and 1% Ox PVA/AC scaffolds 
(*p≤0.05: 1% Ox PVA/W’s J versus 1% Ox PVA/AC scaffold at 7 days from seeding; ▲p≤0.05: Non-
Haemophilic chondrocytes versus Haemophilic chondrocytes at 7 days from seeding). 
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DISCUSSION 
 
 
Articular hyaline cartilage is a soft tissue, which sustains the pressure between the hard 
ends of bones, and it is subjected to particularly complex loads affecting its development 
and maintenance in the body (Ahn et al., 2014; Jung et al., 2008). Because of its limited 
self-healing capacity, as it is an avascular and aneural tissue, even minor cartilage defects 
lead to mechanical joint instability and progressive damage (Jung et al., 2008; Demoor et 
al., 2014). In addition to idiopathic OA, some disorders may cause arthropathy; in such 
cases, OA is referred to as secondary.  
Haemophilic arthopathy is a real burden for patients with haemophilia due to increased 
pain as well as decreased mobility and quality of life. Preventing bleeding through 
prophylaxis enables to avoid or reduce the clinical impact of MSK impairment from 
haemophilic arthropathy and the related consequences in psycho-social development and 
quality of life of these patients (Coppola et al., 2009). However, despite several 
advantages, there are some concerns about this strategy. These are mainly related to the 
high costs but also to the patient’s compliance to therapy (Tagariello et al., 2014) which 
frequently declines (Petrini et Seuser, 2009). Exposure to minimal amounts of blood or 
minimal number of bleedings are sufficient to result in irreversible cartilage damage 
(Roosendaal et al., 2008). 
Cartilage damage is difficult to treat. Until now, considering Non-Haemophilic patients, 
many approaches have been investigated: arthroscopic repair procedures, marrow 
stimulation, osteochondral transfer, autologous chondrocytes transplantation (Farr et al., 
2011), but average long-term results are unsatisfactory. A general drawback of these 
therapeutic strategies is that the newly formed tissue lacks the structural organization of 
cartilage; it has inferior mechanical properties compared to native tissue, and it is 
therefore prone to failure (Jung et al., 2008; Kock et al., 2012). Hence, the goal is to 
produce a repair tissue that has the same functional and mechanical properties of hyaline 
AC (Redman et al., 2005).  
Considering haemophilic patients, as aforementioned, current strategies can only provide 
for pain relief, slowing the progression of damage. Joint replacement surgery is often 
necessary even though, sometimes, it raises several issues such as perioperative and 
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postoperative bleeding, infection and heterotopic bone formation leading to disruption of 
physiotherapy, limp and limitation of walking distance (Asencio et al., 2014).  
To favor the recovery of focal joint damage by promoting the formation of new cartilage 
tissue could be an interesting approach even in haemophilic patients. In particular, it could 
be a smart strategy in the perspective of slowing arthoplasty which in haemophilic patiens 
is performed at younger age than osteoarthritics (Raffini et Manno 2007). 
Cartilage restoration represents a challenge of MSK TE, despite that, the use of matrix 
scaffolds has paved the way for the use of functional tissue substitutes in the treatment of 
cartilage defects (Demoor et al., 2014) 
Biomaterials play an important role in most TE strategies: their selection constitutes a 
key-point for the success of tissue defects treatment following diseases or trauma 
(Armentano et al., 2010). A wide range of natural and synthetic materials has been 
investigated as scaffolding. Amongst synthetic biomaterials, hydrogels are promising 
biomaterials for TE (Toh et Loh 2014) being widely studied for their potential use in soft 
tissue engineering (Gkioni et al., 2010) as space filling agents, vehicles for bioactive 
molecules, and three-dimensional structures for cell proliferation and specific induction 
(Drury et Mooney 2003). Among synthetic polymers, PVA hydrogels stand out: Food 
and Drug Administration (FDA) and Conformité Européenne (CE) already approved 
them for clinical use in humans, due to their excellent biocompatibility and safety (Jensen 
et al., 2011; Ino et al., 2013). They offer unique possibilities to build up engineered 
substitutes, which closely match human tissues for their elasticity and mechanical 
characteristics, water content, and accessibility to solutes (Alves et al., 2011). In 
particular, physically cross-linked PVA hydrogels became attractive to the field of TE for 
repairing and regenerating vessels (Conconi et al., 2014), heart valves (Jiang et al., 2004), 
cornea (Jiang et al., 2014) and cartilage (Gu et al., 1998; Jiang et al., 2011).  
Despite PVA has an extensive history of biomedical applications, yet its current form 
suffers from significant shortcomings: physical cross-linking leads to stronger polymer-
polymer chain interactions, loss of biodegradation rate and less controlled drug release 
(Fejerskov et al., 2013; Martinez et al., 2012). Moreover, when compared to other 
biocompatible polymers, PVA exhibits scant synthetic opportunities: beyond a limited 
choice of solvents, hydroxyl groups appear to be significantly disadvantaged in 
comparison with classic conjugation sites (Alves et al., 2011 Jensen et al., 2011). Hence, 
re-engineering of PVA to improve degradation and control drug release appears highly 
rewarding (Fejerskov et al., 2013). As reported in literature, PVA chemical modifications 
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can be attributed either to direct coupling or activation with 1,1-carbonyldiimidazole or 
4-nitrophenylchloroformate of polymer hydroxyl groups. Both of them aim at introducing 
more convenient sites or functional groups for conjugation, chain extension, and/or 
substrate immobilization (Alves et al., 2011). Such groups include meth(acrylates) 
(Martens et al., 2002), thiol groups (Dicharry et al., 2006; Totani et al., 2008 Ossipov et 
al., 2008), carboxylic groups (Ruiz et al., 2001), halides (Baudrion et al., 1998), aminooxy 
(Ossipov et al., 2008), aldehyde (Ossipov et al., 2007), hydrazide (Ossipov et al., 2007). 
The present study reports the development and the characterization of new chemically 
oxidized PVA for biodegradable cross-linked scaffolds manufacture, able to vehicle 
proteins and promote tissue regeneration. 
To our knowledge, this is the first study that considers oxidation of PVA through chemical 
agents in order to introduce more useful carbonyl groups in the polymer backbone. This 
should make PVA more attractive for TE approaches, implementing biomaterial 
potential. To confirm that oxidation reaction occurred, carbonyl groups were quantified 
by investigating their reaction with DNPH (Wehr et Levine, 2013). As expected, the 
amount of phenylhydrazone derivatives increased proportionally with carbonyl content, 
according to oxidation degree. Beyond chemical characterization, covalent interaction 
with lysozyme allowed us to predict the ability of oxidized PVA to form covalent binding 
even with RGD sequences or oligopeptides, useful to functionalize scaffold surface. 
Following chemical characterization, scaffolds were manufactured. Supports were 
obtained after pouring into moulds polymer solutions that appeared less viscous as 
oxidation degree increased. Aqueous PVA, 1% and 2% PVA solutions were then 
transformed into hydrogels via crystallite formation by freezing-thawing cycles and 
without any chemical cross-linkers, that may lead to toxicity (Kim et al., 2015). Physical 
cross-linked PVA hydrogels show a rubbery elastic behaviour, non-toxicity, and 
biocompatibility. All this makes them more attractive than other synthetic polymers from 
a biomimetic perspective (Gupta et al., 2011). After cross-linking, oxidized PVA 
scaffolds appeared more and more transparent as carbonyl content increased. This can be 
appreciated observing pre-implant scaffolds in Fig. 38 (A,D,G). Moreover, as showed by 
SEM micrographs, oxidization process seemed to influence the resulting cross-linked 
hydrogel surface, appearing 1% and 2% Ox PVA less smooth and regular compared to 
neat PVA.  
In TE, biomaterial selection and scaffold design are strictly dependent on the expected 
outcome. The choice of polymer is crucial in this regard, as it should be specifically 
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tailored for the target tissue to be regenerated or the therapeutic function to be achieved. 
Physical parameters (such as cross-linking density, mechanical strength and crystallinity) 
can surely affect polymer behavior in mimic biological tissues. Our study demonstrated 
that polyvinyl alcohol hydrogels prepared via a freeze-thaw method can be chemically 
modified in order to adjust their properties depending on specific TE applications. 
As far as mechanical properties, PVA possesses better strength and stiffness than its 
chemically oxidized counterparts. This is why hydrogel stiffness results from the 
available hydroxyl groups involved in intra- and inter-molecular hydrogen binding 
(Gupta et al., 2011): so, altering the number of cross-linkable groups per chain, hydrogel 
mechanics changes. It is then reasonable to plan a tissue regenerative strategy based on 
the modulation of the mechanical response of PVA for the replacement of more or less 
resistant soft tissues, such as cartilage, tendons, gut, nerves and vessels. 
Polymeric micelles are supramolecular assemblies of tens of nanometers in diameter, 
which can mimic naturally occurring biological transport systems such as lipoproteins 
and viruses. Recently, polymeric micelles as drug carriers have drawn increasing research 
interests, due to their various advantages in drug delivery applications (Shuai et al., 2004). 
In this regard, the study of the size and surface properties of polymeric micelles have 
crucial importance in achieving modulated drug delivery with remarkable efficacy. 
Because of its hydrophilic nature, PVA can form polymeric micelles in an aqueous milieu. 
The size and size distribution of particles obtained from 1% and 2% oxidized polymer 
solutions were estimated by DLS, in comparison with PVA itself. As showed by our data, 
2% oxidation determines reduction in particles hydrodynamic radius and higher 
polydispersity. Considering that, DLS study allowed us to define the possibility to 
modulate PVA micelles characteristics with the aim to fit polymer drug-delivery capacity 
according to specific needs. 
The hydrogen bonding between hydroxyl groups of PVA and water governs also the 
crystallinity of the bulk PVA material (Nagura et al., 1989): DSC analysis highlighted 
that oxidation treatment can influence even polymer thermal properties, such as melting 
temperature, enthalpy, and crystallinity. In particular, PVA itself was found to be more 
crystalline than its oxidized counterparts and, as such, it is expected to withstand 
degradation for a longer period since the crystalline regions are more resistant to 
hydrolytic attack than the amorphous regions (Santos et al., 1999). This means that 
thermal property study allowed us to predict a higher biodegradation rate for 1% and 2% 
Ox PVA in view of in vivo implant. 
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In addition to their promising biocompatibility characteristics, PVA hydrogels are 
particularly desirable in the biomedical field due to their sensitivity in the physiological 
or biological environment where they are used. In recent years, much research has focused 
on the development and analysis of environmentally responsive hydrogels that can exhibit 
swelling changes due to modification of intrinsic properties or external conditions 
(Peppas et al., 2000). When a biopolymer network is in contact with an aqueous solution 
or a biological fluid, the network starts to swell due to the thermodynamic compatibility 
of the polymer chains and water. The swelling force is counterbalanced by the retractive 
force induced by the cross-links of the network. Swelling equilibrium is reached when 
these two forces are equal. In this study, the maximum swelling index was rapidly reached 
by all investigated hydrogels by 24 h of incubation in PBS, with a major mass increase 
recorded by 2% Ox PVA; however, also 1% Ox PVA showed a significant PBS uptake. 
After 12 days, both 1% and 2% Ox PVA reached equilibrium, showing from then a stable 
swelling behaviour. By taking up large quantities of water solution, hydrophilic polymer 
as PVA can increase their degradation rates; considering that, the enhancement of PBS 
uptake capacity following oxidation treatment may ameliorate PVA biodegradation 
properties. On the other hand, the uptake of water is especially important in the area of 
drug delivery. For PVA hydrogels, gaining substantial swelling ability is the decisive 
parameter for controlling the release of drugs. 
The overall analysis of oxidized PVA physico-chemical characterization clearly 
underlines a direct relationship between mechanical response and thermally-derived 
properties (i.e., crystallinity). In particular, we could speculate that modifying polymer 
crystallinity also affects swelling and degradation behavior, clearly showing that the 
proper modulation of chemical oxidation allows to tailor scaffold characteristics 
according to needs. 
Synthetic polymers are the most widely used materials in TE as GF delivery carriers (Lee 
et Shin, 2007). Such examples concern polyethylene glycol (PEG) (Leslie-Barbick et al., 
2009;Yang et al., 2013), polycaprolactone (PCL) (Cipitria et al., 2013; Kim et al., 2014), 
poly(DL-lactic acid) (PLA) (Yang et al., 2004; Kanczler et al., 2008), poly(d,l-lactide-co-
glycolide) (PLGA) (Kaigler et al., 2006; Jeon et al., 2007; Jung et al., 2012; Rui et al., 
2012) polyurethane (PUR) (Hafeman et al., 2008; Li et al., 2009). 
The advent of protein therapeutic enhanced the need of controlled delivery systems with 
improved pharmacokinetic and pharmacodynamic properties (Censi et al., 2012). As 
demonstrated, the introduction of carbonyls on PVA backbone supported protein-loading 
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ability of scaffolds. This should be ascribable to a possible Schiff-base interaction 
between the amino group of proteins and carbonyls of oxidized PVA and/or to the higher 
swelling ratio. 
GFs are protein molecules specific for intercellular and cell-ECM signalling. Bolus 
administration of GFs would not be effective in tissue healing, since they are readily 
enzymatically digested or deactivated. Moreover, prolonged exposition of the bioactive 
molecules is necessary to support tissue regeneration which normally occurs in long time 
frames. Integrating controlled release strategies within hydrogels may lead to novel 
delivery platform able to control and guide tissue regeneration (Biondi et al., 2008; Stoop, 
2008). Absorption and release of the model protein BSA by hydrogels was found to be 
dependent on polymer oxidation rate. After an initial peak, protein release by 1% Ox and 
2% Ox PVA was sustained up to 144 h. Differently, unmodified PVA showed a 
significantly reduced BSA uptake and subsequent release. These evidences confirm that 
modified scaffolds have high potentiality for in situ protein/drug delivery applications. 
To further underline this potentiality, we considered the effect of chemically modified 
PVA loaded with TGF-β1 on human chondrocytes. In vivo and in vitro data suggest that 
TGF-β1 is substantial (although probably not sufficient) for normal proliferation of 
chondrocytes (Beier et al., 2001). Evidences concerning opposite action of TGF-β1 (Serra 
et al., 1999) were later reconsidered by the same authors: the anti-proliferative effect of 
TGF-β1 on chondrocytes is likely indirect, mediated by the perichondrium, whereas the 
direct (paracrine or autocrine) effects of TGF-β1 on chondrocytes are mitogenic (Beier et 
al., 2001). With regard to our data, TGF-β1-loaded PVA showed enhanced GF release 
capacity when chemically oxidized. In parallel, biological test on AC chondrocytes 
highlighted significant increase (p<0.01) in cell proliferation after exposure to both 
oxidized PVA scaffolds loaded with TGF-β1, in comparison with unmodified PVA and 
untreated cells. Additional in vitro studies will be necessary for complete understanding 
of TGF-β1 effects on chondrocytes; however, it is clear that GF-loading capability of 
non-oxidized PVA is unsuitable to promote cell proliferation.  
As we already stressed, we considered oxidation to promote biodegradation of cross-
linked PVA: oxidation treatment is an important step in biodegradation (Hatanaka et al., 
1996). Most biodegradable polymers suffer from a short half-life due to rapid degradation 
upon implantation, high stiffness, and limited ability to functionalize their surface with 
chemical moieties (Wang et al., 2010). Combining material chemistry and processing 
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technology, it is possible to tune scaffold degradation rate. The aim is to match tissue 
growth rate so that the regenerated tissue may progressively replace the scaffold. 
In the present study, we evaluated in vivo behavior of the three different types of 
biomaterials after subcutis implantation. In particular, a 12-week time interval was 
considered in order to completely evaluate material biodegradability and possible 
inflammatory responses by the surrounding tissues. The gross analysis of explanted 1% 
Ox PVA showed a significant reduction in surface area, while 2% Ox PVA was barely 
recognizable. Conversely, unmodified PVA scaffolds retained their initial size and 
morphology (Fig. 38). 
In spite of difficulties observed during explants sectioning, yet reported in literature 
(Allen et al., 2004), histological analysis of the samples confirmed the absence of severe 
inflammatory reactions, although mild lymphomonocytic infiltration was present in all 
analyzed samples. In particular, it is important to stress that lymphomonocytic cells 
appeared more numerous when 2% Ox PVA had been implanted, suggesting a possible 
role for inflammatory cells in implant reabsorption. In fact, 2% Ox PVA was nearly not 
visible as hydrogel disk, indicating considerable reabsorption and substitution by new 
connective components, as confirmed by SEM results. 
Tailoring a biomaterial is a capital aspect to be considered for the design of medical 
devices. Oxidized PVA hydrogels present tunable degradation behaviour, resulting 
suitable polymers for in vitro engineering of various biological substitutes. By modifying 
PVA original physico-chemical properties, oxidation process showed to enhance 
degradation rate and polymer ability in binding (i.e., lysozyme covalent binding) or 
releasing proteins (i.e., BSA and TGF-β1), optimizing hydrogel potential to be used for 
tissue regeneration studies. It is well known that mechanical properties of PVA hydrogel 
are dependent on polymer concentration, freezing time and temperature, and the number 
of freezing-thawing cycles (Kim et al., 2015). Considering that, future studies will focus 
on fine tuning of such variables, in order to allow a whole management of oxidized PVA 
features for wider TE applications. 
Unfortunatly, cell adherence on PVA hydrogels is inhibited by its highly hydrophilic 
nature (Liu et al., 2010). Most synthetic material-based scaffolds suffer from poor 
anchorage of chondrocytes or stem cells, and incorporation of natural ECMs including 
collagen, fibrin and hyaluronic acid in synthetic scaffolds for cell attachment has been a 
popular approach studied extensively. Synthetic materials provide relatively high 
mechanical strength with a tunable degradation rate, whereas their 
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hydrophobicity/excessive hydrophilic nature and lack of cellular anchorage site are 
drawbacks for their application in TE (Park et Cho, 2010). Many authors demonstrated 
ECM-based scaffold efficacy in creating a more suitable microenvironment to sustain 
cellular adhesion and growth. Extracellular matrix is a reservoir of structural and 
functional proteins like collagens, glycoproteins, proteoglycans, mucins, elastic fibres as 
well as a known repository for a variety of GFs. As in vivo it is progressively degraded 
by proteinases, it can result in the exposure of new recognition sites with potent 
bioactivity (Brown et Badylack, 2014). Conversely, their weak mechanical properties 
make it difficult to use them in load-bearing region such as cartilage. In most cases a 
combination of multiple components to address various features required for culturing 
chondrocytes is desired. Thus, these characteristics of naturally or synthetically originated 
materials drive us to attempt a combination of the two materials in order to afford higher 
mechanical strength, tunable degradation, and cellular attachment (Park et Cho, 2010). 
After having studied and stated oxidized PVA characteristics, we decided to combine Ox 
1% PVA mechanichal properties with ECM features. Our aim was to provide a supportive 
biomimetic microenvironment for chondrocytes to produce AC, taking advantage from 
both PVA and ECM. In particular, we considered an alternative matrix source: we focused 
our attention to a new ECM represented by decellularized W’s J, in comparison with 
decellularized cartilage matrix. 
The research of a new biological ECM useful in cartilage restoration arises from the need 
to identify an easily available resource suitable in sustaining chondrocytes adhesion and 
proliferation, even not specific. Each tissue and organ contains an ECM with unique 
composition that consists of the secreted products of resident cells (Brown et Badylack, 
2014). The main components of W’s J were ECM proteins such as collagen and 
fibronectin. Previous studies demonstrated that W’s J contains growth factors such as 
insulin-like growth factor I (IGF-1), fibroblast growth factor (FGF), transforming growth 
factor β (TGFβ), platelet-derived growth factor (PDGF), epidermal growth factor (EGF) 
and ECM proteins (Hao et al., 2013). These peptides and growth factors induce W’s J 
cells to produce large amounts of collagen and glycosaminoglycans (Sobolewski et al., 
2005) also typical components of cartilage matrix (Poole et al., 2001). The aim of 
decellularization treatment is to decrease the antigenicity of matrices, through an efficient 
removal of cellular and nuclear material, preserving its composition (Grandi et al., 2011). 
Histological analysis of decellularized W’s J and AC ECM demonstrated the 
effectiveness of the treatment. A different number of detergent-enzymatic cycles, 3 and 
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7 cycles respectively, were performed. According to DAPI staining, native W’s J showed 
a higher cellular density in comparison with native AC; nevertheless, its complete 
decellularization was more easily to achieve. This may be related to a different tissue 
macroscopic aspect: while chondrocytes are deeply embedded in matrix, W’s J permits a 
better exposure of its cellular elements to sodium deoxycholate and DNase-I, as well as 
to the osmotic effect of deionized water. To control and quantify W’s J and AC batch-to-
batch variations, decellularized ECMs were analysed as regard their total protein levels. 
Matrix homogenates, gained from different donors, showed a similar profile to BCA 
assay: no significant difference was detected between samples of the same group. 
According to this data, sample-to-sample variations are negligible. Extracellular matrix 
characterization before and after detergent-enzymatic treatment was also achieved by 
means of Masson trichrome and Movat pentachrome stainings. According to Masson 
trichrome, both W’s J and AC maintain their collagen and mucus content (deeply green 
appearance). Movat Pentachrome stain confirmed the concomitant presence of collagen 
and mucus, even after the treatment. The resulting green leading colour is due to the 
overlapping between yellow (referred to collagen and reticular fibres) and blue (referred 
to mucus). However, the detergent-enzymatic treatment seemed to remove or reduce 
fibrinoid elements expression. This ECMs characterization highlighted a similar 
histomorphology for W’s J and cartilage, supporting our theory.  
The chief aim of many authors is to preserve tissue or organ histoarchitecture from a too 
aggressive decellularization treatment; on the contrary, we approached to ECMs in a 
different manner. We take advantage of matrices macromolecules instead of their 
superstructure. ECM homogenates are an interesting and innovative manner of working 
with matrices. Choosing an adequate mould and modulating the needed quantity, the 
liquid suspension obtained can be used to create tailored scaffolds. Furthermore, the 
lyophilization process they subsequently undergo, makes them easy to store. The two 
different lyophilized matrices realized were examined by SEM for their fine structure: 
cartilage derived one appeared more spongy than the W’s J analogue. Physical cross-
linking of lyophilized matrices with PVA solutions led to three-dimensional composite 
scaffolds. 
In collaboration with Transfusion Service, Regional Centre for Blood Diseases and 
Haemophilia Centre of Castelfranco Veneto General Hospital, Treviso, arose the interest 
for haemophilic arthropathy. In particular, the dialogue with the clinician has arisen the 
need to identify a strategy that differed from the approaches already used in clinical. 
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Prophylaxis replacement of clotting factor, which is the gold standard in haemophila, 
prevents bleeding and joint distruction; however, it does not reverse established joint 
damage as well as all the other approaches, even surgical. Hence, the idea was to promote 
the regeneration of cartilage tissue translating in haemophilic patients TE strategies 
already used in non-haemophilic patients.  
Beyond scaffold and adequate stimuli, also cells represent a key element in TE 
approaches. Cell quality could potentially influence the success of the strategy (Pestka et 
al., 2011). In the perspective of carrying out a TE approach for haemophilic arthropathy, 
investigating haemophilic chondrocytes phenotype is an unavoidable requirement. To our 
knowledge in literature, nothing is known about them, as any characterization has been 
performed yet. Stated that, AC chondrocytes from Non-Haemophilic patients were used 
as control. 
Hence, before seeding chondrocytes on scaffolds, gene expression profile and phenotype 
of haemophilic and Non-Haemophilic chondrocytes was investigated through RT-PCR 
and flow citometry analysis. 
The viscoelastic properties of AC arise from the composition of its ECM, which consists 
primarily of type II collagen, but also of collagen type IX and X and a proteoglycan 
termed aggrecan (ACAN) (Ono et al., 2013). Aggrecan is retained in cartilage by binding 
to long filaments of another glycosaminoglycan, hyaluronan (HA), which is synthesized 
at the plasma membrane level by an enzyme called hyaluronan synthase (HAS) 
(Takahashi et al., 2010). Moreover, one of the major non-collagenous proteins in the 
cartilage is COMP, which represents a useful marker of differentiation state of primary 
chondrocytes (Zaucke et al., 2001). The synthesis of this cartilage-specific ECM requires 
the expression of genes associated with the specific chondrocyte phenotype, controlled 
by the transcription factor SOX9 (Ono et al., 2013). According to RT-PCR analysis, both 
cell populations isolated for this study expressed specific cartilage markers at the mRNA 
level, showing a gene expression profile typical of articular chondrocytes. 
Expanded chondrocytes were thus assessed by flow cytometry. We purchased antibodies 
against several CDs, typically used to characterize the phenotype of mesenchymal 
progenitor cells (Pittenger et al. 1999; Grogan et al. 2007) and recently introduced to 
determine the stage of differentiation of human AC (Grogan et al. 2007; Diaz-Romero et 
al., 2005). In this study we conﬁrmed the expression of several articular chondrocyte 
surface markers: the hyaluronan receptor CD44, the ecto-enzyme CD73, the integrins α3 
(CD49c), α5 (CD49e), and the tetraspanin CD151 (Grogan et al. 2007; Diaz-Romero et 
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al., 2005). According to Grogan and colleagues (Grogan et al. 2007), chondrocytes with 
marked chondrogenic capacity express high levels of the hyaluronan receptor CD44, the 
α3 integrin subunit CD49c, and the tetraspanin CD151. These are surface molecules 
involved in the early stages of cartilage development; all of them were present in the 
chondrocytes we investigated. Moreover, these proteins are responsable of establishing 
cell-cell and cell-matrix interactions. These processes are known to be important 
mediators of mesenchymal condensation, which is in turn necessary for initiation of 
chondrogenesis (DeLise et al., 2000). Hence, high expression levels of these membrane 
proteins might increase the propensity of the cells to differentiate and produce cartilage 
ECM. Markers characteristic of mesenchymal progenitor cells, i.e., CD44 and CD73 
(Pittenger et al., 1999), have shown to be expressed in high-chondrogenic-capacity 
populations (Grogan et al. 2007). This suggests that within a chondrocyte culture, 
subpopulations with higher capacity to form cartilage might correspond to those with 
progenitor characteristics. 
After characterization of scaffold histomorphology and chondrocyte gene expression 
profile and specific immunophenotype, we seeded a known cell amount of 20,000 
cells/cm2 on Ox 1% PVA, Ox 1% PVA/W’s J and Ox 1% PVA/AC supports. We 
evaluated chondrocyte adhesion and proliferation at two different end-points: 7 and 14 
days. If Ox 1% PVA itself clearly demonstrated its absolute inability to sustain 
chondrocyte proliferation, cells on composite scaffolds revealed a progressive increasing 
growth trend. At 24 h from seeding, cells adhered on Ox 1% PVA/ECMs, which were 
able to sustain cell proliferation up to the last end-point considered (14 days). According 
to SEM micrographs, chondrocytes cultured on Ox 1% PVA/AC showed a more specific 
morphology and a more tidy orientation on the scaffold surface. In parallel, Ox 1% 
PVA/W’s J revealed a singular attitude to sustain cell proliferation despite its aspecific 
origin. Hence, as stressed also by MTT proliferation assay, our in vitro model confirmed 
the starting hypothesis regarding the possibility to use Wharton’s jelly in composite 
scaffolds that mimic articular cartilage.  
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CONCLUSIONS 
 
 
This work led to the development and characterization of novel PVA-derived 
biomaterials obtained by polymer oxidation. Oxidized PVA polymers showed 
customizable mechanical behaviour, protein-loading ability, biocompatibility and 
biodegradability in vivo, making them suitable for TE applications.  
Moreover, Wharton’s jelly, usually believed a waste product and investigated in literature 
only as source of MSCs, promotes chondrocyte adhesion, representing an idoneous 
biomimetic microenviroment even though its aspecific nature. Combining hydrogel 
potentiality with Wharton’s jelly intrinsic properties we obtained a bio-hybrid scaffold, 
overcoming drawbacks related to the typical inadequacy of synthetic hydrogels in 
promoting cell adhesion and characteristic lack in mechanical properties of ECMs when 
used itself as scaffold.  
This study contributed also to the definition of haemophilic chondrocytes phenotype. Our 
preliminary evidences highlighted the chance of using these cells for autologous implant. 
In vivo exposure to blood seems not to have altered their potential in synthetizing matrix-
related proteins as well as surface markers typically involved in cell-cell and cell-matrix 
interactions. Finally, considering the impact of the primary osteoarthritis, our composite 
scaffold may be considered also as an innovative, easily available and inexpensive 
support for cartilage restoration even in Non-Haemophilic patients. 
Further investigations are necessary to evaluate phenotype maintenance of chondrocytes, 
and hydrogels behaviour after implantation in the treatment of focal articular cartilage 
defects. 
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